MXPA01011220A - Shampoos providing a superior combination of anti-dandruff efficacy and conditioning - Google Patents
Shampoos providing a superior combination of anti-dandruff efficacy and conditioningInfo
- Publication number
- MXPA01011220A MXPA01011220A MXPA/A/2001/011220A MXPA01011220A MXPA01011220A MX PA01011220 A MXPA01011220 A MX PA01011220A MX PA01011220 A MXPA01011220 A MX PA01011220A MX PA01011220 A MXPA01011220 A MX PA01011220A
- Authority
- MX
- Mexico
- Prior art keywords
- hair
- conditioning
- shampoo
- composition
- index
- Prior art date
Links
- 230000003750 conditioning Effects 0.000 title claims abstract description 174
- 239000002453 shampoo Substances 0.000 title claims abstract description 173
- 239000000203 mixture Substances 0.000 claims abstract description 313
- 210000004209 Hair Anatomy 0.000 claims abstract description 177
- 125000002091 cationic group Chemical group 0.000 claims abstract description 124
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 116
- 229920000642 polymer Polymers 0.000 claims abstract description 110
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 230000036912 Bioavailability Effects 0.000 claims abstract description 23
- 230000035514 bioavailability Effects 0.000 claims abstract description 23
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 21
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 15
- -1 aminaxyl Substances 0.000 claims description 108
- 229920001296 polysiloxane Polymers 0.000 claims description 95
- 239000004094 surface-active agent Substances 0.000 claims description 53
- 239000002245 particle Substances 0.000 claims description 29
- 239000000375 suspending agent Substances 0.000 claims description 23
- 240000005497 Cyamopsis tetragonoloba Species 0.000 claims description 21
- 230000003698 anagen phase Effects 0.000 claims description 21
- 230000003779 hair growth Effects 0.000 claims description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 230000001105 regulatory Effects 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 13
- 229920002678 cellulose Chemical class 0.000 claims description 13
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 12
- 239000001913 cellulose Chemical class 0.000 claims description 11
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Glycol distearate Chemical group CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 claims description 9
- XMAYWYJOQHXEEK-OZXSUGGESA-N Ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 9
- 229960004125 ketoconazole Drugs 0.000 claims description 9
- 150000001735 carboxylic acids Chemical class 0.000 claims description 8
- 239000003112 inhibitor Substances 0.000 claims description 8
- WCGUUGGRBIKTOS-RRHGHHQTSA-N Ursolic acid Natural products O=C(O)[C@@]12[C@@H]([C@@H](C)[C@@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@]4(C)[C@H](C(C)(C)[C@@H](O)CC4)CC3)CC=1)CC2 WCGUUGGRBIKTOS-RRHGHHQTSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical class [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- 150000003751 zinc Chemical class 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- PMATZTZNYRCHOR-CGLBZJNRSA-N (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17 Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims description 4
- 230000000875 corresponding Effects 0.000 claims description 4
- GDLBFKVLRPITMI-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound ClC1=CC=C2NC(C)=NS(=O)(=O)C2=C1 GDLBFKVLRPITMI-UHFFFAOYSA-N 0.000 claims description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3β-hydroxy-Olean-12-en-28-oic acid Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 claims description 3
- BDJRBEYXGGNYIS-UHFFFAOYSA-N Azelaic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 3
- 108010036949 Cyclosporine Proteins 0.000 claims description 3
- 229960000978 Cyproterone Acetate Drugs 0.000 claims description 3
- UWFYSQMTEOIJJG-FDTZYFLXSA-N Cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims description 3
- CXOFVDLJLONNDW-UHFFFAOYSA-N Epinat Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 claims description 3
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Loniten Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 claims description 3
- 229960003632 Minoxidil Drugs 0.000 claims description 3
- 229940100243 Oleanolic Acid Drugs 0.000 claims description 3
- MIJYXULNPSFWEK-LXLHWSNGSA-N Oleanolic acid Chemical class C1C[C@H](O)C(C)(C)[C@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@@H]5C4=CC[C@H]3[C@]21C MIJYXULNPSFWEK-LXLHWSNGSA-N 0.000 claims description 3
- 229960002036 Phenytoin Drugs 0.000 claims description 3
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims description 3
- 229940035722 Triiodothyronine Drugs 0.000 claims description 3
- 229960001265 ciclosporin Drugs 0.000 claims description 3
- 229960004042 diazoxide Drugs 0.000 claims description 3
- 229950004592 liothyronine Drugs 0.000 claims description 3
- 102000004257 potassium channel family Human genes 0.000 claims description 3
- 108020001213 potassium channel family Proteins 0.000 claims description 3
- 150000007949 saponins Chemical class 0.000 claims description 3
- 235000017709 saponins Nutrition 0.000 claims description 3
- 150000003648 triterpenes Chemical class 0.000 claims description 3
- 229940096998 ursolic acid Drugs 0.000 claims description 3
- 238000009736 wetting Methods 0.000 claims description 3
- QGJZLNKBHJESQX-FZFNOLFKSA-N Betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 claims description 2
- QGJZLNKBHJESQX-CASBDLHJSA-N Betulinic acid Natural products O=C(O)[C@@]12[C@@H]([C@@H](C(=C)C)CC1)[C@@H]1[C@](C)([C@@]3(C)[C@@H]([C@]4(C)[C@H](C(C)(C)[C@@H](O)CC4)CC3)CC1)CC2 QGJZLNKBHJESQX-CASBDLHJSA-N 0.000 claims description 2
- KQJSQWZMSAGSHN-JJWQIEBTSA-N Celastrol Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)[C@](C)(C(O)=O)CC[C@]1(C)CC[C@]2(C)C4=CC=C1C3=CC(=O)C(O)=C1C KQJSQWZMSAGSHN-JJWQIEBTSA-N 0.000 claims description 2
- 229940108066 Coal Tar Drugs 0.000 claims description 2
- JWJOTENAMICLJG-QWBYCMEYSA-N Dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 claims description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N Finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 claims description 2
- 229940041033 Macrolides Drugs 0.000 claims description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N Maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 claims description 2
- RJKFOVLPORLFTN-STHVQZNPSA-N Progesterone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC(=O)CC4)CC3)CC2)CC1 RJKFOVLPORLFTN-STHVQZNPSA-N 0.000 claims description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Syngestrets Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 2
- 229960000306 Zinc Gluconate Drugs 0.000 claims description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- 239000011280 coal tar Substances 0.000 claims description 2
- 229960004199 dutasteride Drugs 0.000 claims description 2
- 229960004039 finasteride Drugs 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 2
- 230000011987 methylation Effects 0.000 claims description 2
- 239000000186 progesterone Substances 0.000 claims description 2
- 229960003387 progesterone Drugs 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- SLJTWDNVZKIDAU-UXEXATSUSA-N Betulonic acid Natural products C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@H]5[C@H]4CC[C@@H]3[C@]21C SLJTWDNVZKIDAU-UXEXATSUSA-N 0.000 claims 2
- 229960002255 azelaic acid Drugs 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 210000004761 Scalp Anatomy 0.000 abstract description 13
- 239000000047 product Substances 0.000 description 65
- 125000004432 carbon atoms Chemical group C* 0.000 description 58
- 125000000217 alkyl group Chemical group 0.000 description 38
- 239000012530 fluid Substances 0.000 description 33
- 125000000129 anionic group Chemical group 0.000 description 26
- 210000003491 Skin Anatomy 0.000 description 25
- 229920001223 polyethylene glycol Polymers 0.000 description 24
- 229920001577 copolymer Polymers 0.000 description 22
- 239000003921 oil Substances 0.000 description 22
- 235000019198 oils Nutrition 0.000 description 22
- 239000004480 active ingredient Substances 0.000 description 20
- 238000004140 cleaning Methods 0.000 description 20
- 229920002050 silicone resin Polymers 0.000 description 20
- 239000011780 sodium chloride Substances 0.000 description 19
- 229920002907 Guar gum Polymers 0.000 description 18
- 239000000665 guar gum Substances 0.000 description 18
- 235000010417 guar gum Nutrition 0.000 description 18
- 229960002154 guar gum Drugs 0.000 description 18
- 150000002194 fatty esters Chemical class 0.000 description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 17
- 150000003839 salts Chemical class 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 150000002148 esters Chemical class 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 230000000670 limiting Effects 0.000 description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 16
- 239000004215 Carbon black (E152) Substances 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 229920001817 Agar Polymers 0.000 description 14
- 239000008272 agar Substances 0.000 description 14
- 125000003118 aryl group Chemical group 0.000 description 14
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 description 14
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 14
- 125000001931 aliphatic group Chemical group 0.000 description 13
- 230000000845 anti-microbial Effects 0.000 description 13
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 13
- 230000012010 growth Effects 0.000 description 13
- 150000002430 hydrocarbons Chemical class 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 description 12
- 229940068196 placebo Drugs 0.000 description 12
- 239000000902 placebo Substances 0.000 description 12
- 125000003342 alkenyl group Chemical group 0.000 description 11
- 201000004384 alopecia Diseases 0.000 description 11
- 235000010980 cellulose Nutrition 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 11
- 241000282898 Sus scrofa Species 0.000 description 10
- 150000004676 glycans Polymers 0.000 description 10
- 150000004804 polysaccharides Polymers 0.000 description 10
- 229920000289 Polyquaternium Polymers 0.000 description 9
- 150000001412 amines Chemical class 0.000 description 9
- 230000003676 hair loss Effects 0.000 description 9
- 229920000098 polyolefin Polymers 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 230000035807 sensation Effects 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- WHMDPDGBKYUEMW-UHFFFAOYSA-N 2-Mercaptopyridine Chemical class SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 8
- 230000001965 increased Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- BTBJBAZGXNKLQC-UHFFFAOYSA-N Ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 7
- 125000005466 alkylenyl group Chemical group 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 150000001768 cations Chemical class 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 238000005755 formation reaction Methods 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000003002 pH adjusting agent Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 150000003871 sulfonates Chemical class 0.000 description 7
- 239000002562 thickening agent Substances 0.000 description 7
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 7
- 239000004034 viscosity adjusting agent Substances 0.000 description 7
- URZHQOCYXDNFGN-UHFFFAOYSA-N 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane Chemical group FC(F)(F)CC[Si]1(C)O[Si](C)(CCC(F)(F)F)O[Si](C)(CCC(F)(F)F)O1 URZHQOCYXDNFGN-UHFFFAOYSA-N 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N Adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N Selsun Blue Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 description 6
- 229940091251 Zinc Supplements Drugs 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000003749 cleanliness Effects 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 229920001519 homopolymer Polymers 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-Dichlorophenoxyacetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 5
- LQZZUXJYWNFBMV-UHFFFAOYSA-N Dodecanol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- AKEJUJNQAAGONA-UHFFFAOYSA-N Sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 150000001336 alkenes Chemical class 0.000 description 5
- 230000003042 antagnostic Effects 0.000 description 5
- 239000005557 antagonist Substances 0.000 description 5
- 239000002216 antistatic agent Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine zwitterion Chemical class C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 5
- 229960005265 selenium sulfide Drugs 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical class O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 4
- 229940063953 AMMONIUM LAURYL SULFATE Drugs 0.000 description 4
- 241000555676 Malassezia Species 0.000 description 4
- 241000539716 Mea Species 0.000 description 4
- 229920001083 Polybutene Polymers 0.000 description 4
- 229920001451 Polypropylene glycol Polymers 0.000 description 4
- 210000003813 Thumb Anatomy 0.000 description 4
- OTPSWLRZXRHDNX-UHFFFAOYSA-L Zinc pyrithione Chemical compound S1C2=CC=CC=N2=O[Zn]21O=N1=CC=CC=C1S2 OTPSWLRZXRHDNX-UHFFFAOYSA-L 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- CLLKUSRBGZGQSF-UHFFFAOYSA-N dodecyl hydrogen sulfate;ethane-1,2-diol;2-(2-hydroxyethylamino)ethanol Chemical compound OCCO.OCCNCCO.CCCCCCCCCCCCOS(O)(=O)=O CLLKUSRBGZGQSF-UHFFFAOYSA-N 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical group 0.000 description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000003346 palm kernel oil Substances 0.000 description 4
- 235000019865 palm kernel oil Nutrition 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000001603 reducing Effects 0.000 description 4
- 150000004756 silanes Chemical class 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 239000004711 α-olefin Substances 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 240000007170 Cocos nucifera Species 0.000 description 3
- WSDISUOETYTPRL-UHFFFAOYSA-N DMDM hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000195955 Equisetum hyemale Species 0.000 description 3
- 210000003811 Fingers Anatomy 0.000 description 3
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229940093629 ISOPROPYL ISOSTEARATE Drugs 0.000 description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M Sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 150000001408 amides Chemical group 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cells Anatomy 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 238000011068 load Methods 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 125000004430 oxygen atoms Chemical group O* 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 230000002335 preservative Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 150000003141 primary amines Chemical class 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reduced Effects 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 230000001953 sensory Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000006277 sulfonation reaction Methods 0.000 description 3
- 239000005495 thyroid hormone Substances 0.000 description 3
- 125000003944 tolyl group Chemical group 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940043810 zinc pyrithione Drugs 0.000 description 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[[(2R,3S,4R,5S,6R)-4,5,6-trihydroxy-3-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N (±)-Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-Hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-Octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical group CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 2
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 229940030495 ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N Coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 2
- AFFLGGQVNFXPEV-UHFFFAOYSA-N Decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- 229940065521 Glucocorticoid inhalants for obstructive airway disease Drugs 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N Glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 229940093912 Gynecological Sulfonamides Drugs 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N Hexadecane Chemical class CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N Hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N Icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N Isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940057905 Laureth-3 Drugs 0.000 description 2
- 241001124569 Lycaenidae Species 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N Maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N Methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 241000282372 Panthera onca Species 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O Pyridinium Chemical group C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 2
- 229940037312 STEARAMIDE Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940079862 Sodium Lauryl Sarcosinate Drugs 0.000 description 2
- 229940037128 Systemic Glucocorticoids Drugs 0.000 description 2
- 229940036555 Thyroid hormones Drugs 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940029983 VITAMINS Drugs 0.000 description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 2
- SRBFZHDQGSBBOR-SQOUGZDYSA-N Xylose Natural products O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000002280 anti-androgenic Effects 0.000 description 2
- 230000003110 anti-inflammatory Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 229940027983 antiseptics and disinfectants Quaternary ammonium compounds Drugs 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 125000004429 atoms Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000005354 coacervation Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 150000002118 epoxides Chemical group 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 125000005908 glyceryl ester group Chemical group 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic Effects 0.000 description 2
- 125000005020 hydroxyalkenyl group Chemical group 0.000 description 2
- 210000003702 immature single positive T cell Anatomy 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 229940079867 intestinal antiinfectives Sulfonamides Drugs 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 150000004797 ketoamides Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical group CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 125000005528 methosulfate group Chemical group 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 102000035365 modified proteins Human genes 0.000 description 2
- 108091005569 modified proteins Proteins 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 229940005938 ophthalmologic antiinfectives Sulfonamides Drugs 0.000 description 2
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 2
- 229920001888 polyacrylic acid Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 230000003362 replicative Effects 0.000 description 2
- 229940071089 sarcosinate Drugs 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-M sarcosinate Chemical compound CNCC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-M 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical class CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- DIORMHZUUKOISG-UHFFFAOYSA-M sulfoformate Chemical compound OC(=O)S([O-])(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-M 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229940026752 topical Sulfonamides Drugs 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 125000005208 trialkylammonium group Chemical group 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 239000011778 trisodium citrate Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamins Natural products 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- SHGAZHPCJJPHSC-XFYACQKRSA-N (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid Chemical compound OC(=O)/C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-XFYACQKRSA-N 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N 1,4-Butanediol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FILVIKOEJGORQS-UHFFFAOYSA-N 1,5-dimethylpyrrolidin-2-one Chemical compound CC1CCC(=O)N1C FILVIKOEJGORQS-UHFFFAOYSA-N 0.000 description 1
- AZUXKVXMJOIAOF-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-ol Chemical compound CC(O)COCC(C)O AZUXKVXMJOIAOF-UHFFFAOYSA-N 0.000 description 1
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1-Dodecene Chemical compound CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical group CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- KMTMJNIEJGRRFY-UHFFFAOYSA-N 1H-pyridine-2-thione;zinc Chemical compound [Zn].SC1=CC=CC=N1 KMTMJNIEJGRRFY-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 1
- RRLKOZCPQXMIIJ-UHFFFAOYSA-N 2,4,4-trimethylnonane Chemical compound CCCCCC(C)(C)CC(C)C RRLKOZCPQXMIIJ-UHFFFAOYSA-N 0.000 description 1
- RWBHOLZDSPWSPK-UHFFFAOYSA-N 2,4,4-trimethylundecane Chemical compound CCCCCCCC(C)(C)CC(C)C RWBHOLZDSPWSPK-UHFFFAOYSA-N 0.000 description 1
- YYRFKEZGNCUVCQ-UHFFFAOYSA-N 2,6-diethyl-3-methylbenzamide Chemical compound CCC1=CC=C(C)C(CC)=C1C(N)=O YYRFKEZGNCUVCQ-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N 2-Pyrrolidone Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-TUJWMRSMSA-N 2-[(2S)-butan-2-yl]-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-TUJWMRSMSA-N 0.000 description 1
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- CYMRPDYINXWJFU-UHFFFAOYSA-N 2-carbamoylbenzoic acid Chemical class NC(=O)C1=CC=CC=C1C(O)=O CYMRPDYINXWJFU-UHFFFAOYSA-N 0.000 description 1
- CCFWAONPPYWNDM-UHFFFAOYSA-N 2-ethylhexyl nonanoate Chemical compound CCCCCCCCC(=O)OCC(CC)CCCC CCFWAONPPYWNDM-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-ZHACJKMWSA-N 2-hydroxypropyl (E)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-ZHACJKMWSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-hydroxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- OJDDJQYSKDIXOE-UHFFFAOYSA-N 2-tridecoxyethanol Chemical compound CCCCCCCCCCCCCOCCO OJDDJQYSKDIXOE-UHFFFAOYSA-N 0.000 description 1
- NGRYSBPZIYVTHZ-UHFFFAOYSA-N 3-[3-(dimethylamino)propoxy]-N,N-dimethylpropan-1-amine Chemical compound CN(C)CCCOCCCN(C)C NGRYSBPZIYVTHZ-UHFFFAOYSA-N 0.000 description 1
- MARYDOMJDFATPK-UHFFFAOYSA-N 3-hydroxy-1H-pyridine-2-thione Chemical compound OC1=CC=CN=C1S MARYDOMJDFATPK-UHFFFAOYSA-N 0.000 description 1
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 1
- XTQUSEDRZLDHRC-UHFFFAOYSA-N 3-octadecanoyloxybutyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCCCCCCCCCC XTQUSEDRZLDHRC-UHFFFAOYSA-N 0.000 description 1
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-Methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 1
- IBYCEACZVUOBIV-UHFFFAOYSA-N 4-methylpentyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC(C)C IBYCEACZVUOBIV-UHFFFAOYSA-N 0.000 description 1
- AUGIYYGVQDZOLU-UHFFFAOYSA-N 4-methylpentyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCC(C)C AUGIYYGVQDZOLU-UHFFFAOYSA-N 0.000 description 1
- YVIVRJLWYJGJTJ-UHFFFAOYSA-N 5-methylpyrrolidin-2-one Chemical compound CC1CCC(=O)N1 YVIVRJLWYJGJTJ-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- 229940083920 AMMONIUM LAURETH-3 SULFATE Drugs 0.000 description 1
- ZDQSOHOQTUFQEM-NURRSENYSA-N ASCOMYCIN Chemical class C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-NURRSENYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241000811606 Ancora Species 0.000 description 1
- 229940095077 BEHENTRIMONIUM METHOSULFATE Drugs 0.000 description 1
- 229940050390 Benzoate Drugs 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N Benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 1
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 1
- 210000000941 Bile Anatomy 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N Bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- ZNSMNVMLTJELDZ-UHFFFAOYSA-N Bis(chloroethyl) ether Chemical compound ClCCOCCCl ZNSMNVMLTJELDZ-UHFFFAOYSA-N 0.000 description 1
- UZBDLHYCYNXFRF-UHFFFAOYSA-N C(=CC)[SiH2]Cl Chemical class C(=CC)[SiH2]Cl UZBDLHYCYNXFRF-UHFFFAOYSA-N 0.000 description 1
- FXALIOUHXMVTMJ-UHFFFAOYSA-N CCCCCCCCCCCC([Na])=O Chemical compound CCCCCCCCCCCC([Na])=O FXALIOUHXMVTMJ-UHFFFAOYSA-N 0.000 description 1
- 229960002788 CETRIMONIUM CHLORIDE Drugs 0.000 description 1
- 210000002421 Cell Wall Anatomy 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M Cetrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 210000001520 Comb Anatomy 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- 240000007582 Corylus avellana Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 229940119017 Cyclosporine Drugs 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-Galacturonic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229940014772 DIMETHYL SEBACATE Drugs 0.000 description 1
- 229940079886 DISODIUM LAURYL SULFOSUCCINATE Drugs 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N DMA Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- PGIBJVOPLXHHGS-UHFFFAOYSA-N Di-n-decyl phthalate Chemical compound CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCC PGIBJVOPLXHHGS-UHFFFAOYSA-N 0.000 description 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N Dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N Dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N Dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229960000525 Diphenhydramine Hydrochloride Drugs 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical class CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- VZWGRQBCURJOMT-UHFFFAOYSA-N Dodecyl acetate Chemical compound CCCCCCCCCCCCOC(C)=O VZWGRQBCURJOMT-UHFFFAOYSA-N 0.000 description 1
- 241001354498 Dracophyllum minimum Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- RGXWDWUGBIJHDO-UHFFFAOYSA-N Ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCC RGXWDWUGBIJHDO-UHFFFAOYSA-N 0.000 description 1
- LZCLXQDLBQLTDK-UHFFFAOYSA-N Ethyl lactate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 1
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N Flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N Fucose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229940074049 GLYCERYL DILAURATE Drugs 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N Galactosamine Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229960002442 Glucosamine Drugs 0.000 description 1
- 229940100242 Glycol Stearate Drugs 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N Glycol stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003780 Hair Follicle Anatomy 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N Heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Hiestrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N Hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229960003444 IMMUNOSUPPRESSANTS Drugs 0.000 description 1
- 229940078545 ISOCETYL STEARATE Drugs 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Incidol Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 229940076144 Interleukin-10 Drugs 0.000 description 1
- 102000003814 Interleukin-10 Human genes 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 229940100601 Interleukin-6 Drugs 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N Inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 229940029339 Inulin Drugs 0.000 description 1
- 229940045996 Isethionic Acid Drugs 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N Isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- UJPPXNXOEVDSRW-UHFFFAOYSA-N Isopropyl_laurate Chemical compound CCCCCCCCCCCC(=O)OC(C)C UJPPXNXOEVDSRW-UHFFFAOYSA-N 0.000 description 1
- 229960005280 Isotretinoin Drugs 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N LSD Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 229940001447 Lactate Drugs 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229940039717 Lanolin Drugs 0.000 description 1
- 240000001422 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
- 229950002454 Lysergide Drugs 0.000 description 1
- 210000004759 MCP Anatomy 0.000 description 1
- 229940069822 MONOETHANOLAMINE LAURYL SULFATE Drugs 0.000 description 1
- LUEWUZLMQUOBSB-GFVSVBBRSA-N Mannan Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N Methylsulfonylmethane Chemical group CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N Minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 229960004023 Minocycline Drugs 0.000 description 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N Mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
- KKXWPVVBVWBKBL-UHFFFAOYSA-N N,N-diethylethanamine;dodecyl hydrogen sulfate Chemical compound CC[NH+](CC)CC.CCCCCCCCCCCCOS([O-])(=O)=O KKXWPVVBVWBKBL-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N Oleyl alcohol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 1
- 229940116985 POTASSIUM LAURYL SULFATE Drugs 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229940101267 Panthenol Drugs 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N Pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000008426 Persea americana Species 0.000 description 1
- 240000005158 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000690470 Plantago princeps Species 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- 229920000691 Poly[bis(2-chloroethyl) ether-alt-1,3-bis[3-(dimethylamino)propyl]urea] Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M Potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 229910018210 SexSy Inorganic materials 0.000 description 1
- 229940095673 Shampoo Product Drugs 0.000 description 1
- 210000002832 Shoulder Anatomy 0.000 description 1
- FDNAPBUWERUEDA-UHFFFAOYSA-N Silicon tetrachloride Chemical class Cl[Si](Cl)(Cl)Cl FDNAPBUWERUEDA-UHFFFAOYSA-N 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H Sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-M Sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 229940077400 TRIDECETH-12 Drugs 0.000 description 1
- 229940057400 TRIHYDROXYSTEARIN Drugs 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- BGHCVCJVXZWKCC-UHFFFAOYSA-N Tetradecane Chemical class CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 229940117972 Triolein Drugs 0.000 description 1
- 229940046728 Tumor necrosis factor alpha (TNF-) inhibitors Drugs 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 229920001567 Vinyl ester Polymers 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229940046008 Vitamin D Drugs 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229960003487 Xylose Drugs 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- YYDZACXIVKPEAI-ZPHPHTNESA-N [(Z)-octadec-9-enyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC YYDZACXIVKPEAI-ZPHPHTNESA-N 0.000 description 1
- WMOBLRURFXZUMY-MSUUIHNZSA-N [(Z)-octadec-9-enyl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC WMOBLRURFXZUMY-MSUUIHNZSA-N 0.000 description 1
- XAQHXGSHRMHVMU-UHFFFAOYSA-N [S].[S] Chemical compound [S].[S] XAQHXGSHRMHVMU-UHFFFAOYSA-N 0.000 description 1
- JUKCRRXUVIMUKK-UHFFFAOYSA-N [Se]=S.[Se]=S Chemical compound [Se]=S.[Se]=S JUKCRRXUVIMUKK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229960005339 acitretin Drugs 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005819 alkenylalkoxy group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000004171 alkoxy aryl group Chemical group 0.000 description 1
- 125000000033 alkoxyamino group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- IHUNBGSDBOWDMA-AQFIFDHZSA-N all-trans-acitretin Chemical compound COC1=CC(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1C IHUNBGSDBOWDMA-AQFIFDHZSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 230000001773 anti-convulsant Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001479 arabinose derivatives Chemical class 0.000 description 1
- 125000005018 aryl alkenyl group Chemical group 0.000 description 1
- 125000005418 aryl aryl group Chemical group 0.000 description 1
- FGTOZJXFOAPXMR-UHFFFAOYSA-N azane;2,4-dimethylbenzenesulfonic acid Chemical compound [NH4+].CC1=CC=C(S([O-])(=O)=O)C(C)=C1 FGTOZJXFOAPXMR-UHFFFAOYSA-N 0.000 description 1
- UPDATVKGFTVGQJ-UHFFFAOYSA-O azanium;sodium Chemical compound [NH4+].[Na+] UPDATVKGFTVGQJ-UHFFFAOYSA-O 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960000333 benzydamine Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- KQNZLOUWXSAZGD-UHFFFAOYSA-N benzylperoxymethylbenzene Chemical compound C=1C=CC=CC=1COOCC1=CC=CC=C1 KQNZLOUWXSAZGD-UHFFFAOYSA-N 0.000 description 1
- 229960000074 biopharmaceuticals Drugs 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- ZDWGXBPVPXVXMQ-UHFFFAOYSA-N bis(2-ethylhexyl) nonanedioate Chemical compound CCCCC(CC)COC(=O)CCCCCCCC(=O)OCC(CC)CCCC ZDWGXBPVPXVXMQ-UHFFFAOYSA-N 0.000 description 1
- MKHVZQXYWACUQC-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;dodecyl sulfate Chemical compound OCCNCCO.CCCCCCCCCCCCOS(O)(=O)=O MKHVZQXYWACUQC-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- NZIKRHKSEITLPS-UHFFFAOYSA-N butane-1,3-diol;octadecanoic acid Chemical compound CC(O)CCO.CCCCCCCCCCCCCCCCCC(O)=O NZIKRHKSEITLPS-UHFFFAOYSA-N 0.000 description 1
- NDKYEUQMPZIGFN-UHFFFAOYSA-N butyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC NDKYEUQMPZIGFN-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- 125000003346 cobalamin group Chemical group 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 230000001143 conditioned Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- KBODESQIOVVMAI-UHFFFAOYSA-N decyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCC KBODESQIOVVMAI-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- SHLKYEAQGUCTIO-UHFFFAOYSA-N diazanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].[NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O SHLKYEAQGUCTIO-UHFFFAOYSA-N 0.000 description 1
- DVLXEVMGHXWBOZ-UHFFFAOYSA-N dibenzyl decanedioate Chemical compound C=1C=CC=CC=1COC(=O)CCCCCCCCC(=O)OCC1=CC=CC=C1 DVLXEVMGHXWBOZ-UHFFFAOYSA-N 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- RISLXYINQFKFRL-UHFFFAOYSA-N dibutyl nonanedioate Chemical compound CCCCOC(=O)CCCCCCCC(=O)OCCCC RISLXYINQFKFRL-UHFFFAOYSA-N 0.000 description 1
- LBXQUCHUHCBNTC-UHFFFAOYSA-N dibutyl octanedioate Chemical compound CCCCOC(=O)CCCCCCC(=O)OCCCC LBXQUCHUHCBNTC-UHFFFAOYSA-N 0.000 description 1
- 229940031954 dibutyl sebacate Drugs 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- HCQHIEGYGGJLJU-UHFFFAOYSA-N didecyl hexanedioate Chemical compound CCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCC HCQHIEGYGGJLJU-UHFFFAOYSA-N 0.000 description 1
- ONKUXPIBXRRIDU-UHFFFAOYSA-N diethyl decanedioate Chemical compound CCOC(=O)CCCCCCCCC(=O)OCC ONKUXPIBXRRIDU-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ALOUNLDAKADEEB-UHFFFAOYSA-N dimethyl decanedioate Chemical compound COC(=O)CCCCCCCCC(=O)OC ALOUNLDAKADEEB-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- DRUKNYVQGHETPO-UHFFFAOYSA-N dimethyl nonanedioate Chemical compound COC(=O)CCCCCCCC(=O)OC DRUKNYVQGHETPO-UHFFFAOYSA-N 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 description 1
- QIVLQXGSQSFTIF-UHFFFAOYSA-M docosyl(trimethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C QIVLQXGSQSFTIF-UHFFFAOYSA-M 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- QVBODZPPYSSMEL-UHFFFAOYSA-N dodecyl sulfate;2-hydroxyethylazanium Chemical compound NCCO.CCCCCCCCCCCCOS(O)(=O)=O QVBODZPPYSSMEL-UHFFFAOYSA-N 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- DZTJRUYDMKJKPJ-UHFFFAOYSA-N ethane-1,2-diol;octadecanoic acid;propane-1,2,3-triol Chemical compound OCCO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O DZTJRUYDMKJKPJ-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 1
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 1
- YYZUSRORWSJGET-UHFFFAOYSA-N ethyl octanoate Chemical compound CCCCCCCC(=O)OCC YYZUSRORWSJGET-UHFFFAOYSA-N 0.000 description 1
- 229940005667 ethyl salicylate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229960002074 flutamide Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N furane Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 231100001007 hair change Toxicity 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000003944 halohydrins Chemical group 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N hexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 1
- RSRQBSGZMPVCOI-UHFFFAOYSA-N hexadecyl propanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CC RSRQBSGZMPVCOI-UHFFFAOYSA-N 0.000 description 1
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O imidazolium Chemical group C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 230000001861 immunosuppresant Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M laurate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 229960002744 mometasone furoate Drugs 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- CMCJFUXWBBHIIL-UHFFFAOYSA-N octadecanoic acid;propane-1,2-diol Chemical class CC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CMCJFUXWBBHIIL-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- BBNYLDSWVXSNOQ-UHFFFAOYSA-N oxolane-2-carbaldehyde Chemical compound O=CC1CCCO1 BBNYLDSWVXSNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N palmityl palmitate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 230000000149 penetrating Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- GTCCGKPBSJZVRZ-UHFFFAOYSA-N pentane-2,4-diol Chemical compound CC(O)CC(C)O GTCCGKPBSJZVRZ-UHFFFAOYSA-N 0.000 description 1
- 230000001175 peptic Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000737 periodic Effects 0.000 description 1
- 235000005426 persea americana Nutrition 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000013966 potassium salts of fatty acid Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910000338 selenium disulfide Inorganic materials 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000013875 sodium salts of fatty acid Nutrition 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- RTVVXRKGQRRXFJ-UHFFFAOYSA-N sodium;2-sulfobutanedioic acid Chemical compound [Na].OC(=O)CC(C(O)=O)S(O)(=O)=O RTVVXRKGQRRXFJ-UHFFFAOYSA-N 0.000 description 1
- XZZDWCJZCAQFDF-UHFFFAOYSA-N sodium;tridecyl benzenesulfonate Chemical compound [Na].CCCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 XZZDWCJZCAQFDF-UHFFFAOYSA-N 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical class [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 230000000475 sunscreen Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N t-BuOH Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 230000000929 thyromimetic Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 125000004954 trialkylamino group Chemical group 0.000 description 1
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical class CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 1
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-O trimethylammonium Chemical compound C[NH+](C)C GETQZCLCWQTVFV-UHFFFAOYSA-O 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002451 tumor necrosis factor inhibitor Substances 0.000 description 1
- 230000000261 vasodilator Effects 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 101710010882 ypwA Proteins 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Abstract
Disclosed are shampoo compositions that provide a superior combination of anti-dandruff efficacy and conditioning, and a method of cleansing and conditioning the hair comprising applying to the hair and scalp an amount of said compositions. The anti-dandruff and conditioning shampoos comprise:(A) from about 5%to about 50%, by weight, of an anionic surfactant;(B) from about 0.01%to about 10%, by weight, of a non-volatile conditioning agent;(C) from about 0.1%to about 4%, by weight, of an anti-dandruff agent;(D) from about 0.02%to about 5%, by weight, of at least one cationic polymer;and (E) water. The compositions (A) have a bioavailability/coverage index value, as defined herein, of at least about 1.25;(B) have a first conditioning index value, as defined herein, of less than or equal to about 1.0;(C) have a second conditioning index value, as defined herein, of at least 1.5;and (D) have a minimal inhibitory concentration index value, as defined herein, of at least 0.125.
Description
SHAMPOO THAT PROVIDES A SUPERIOR COMBINATION OF ANTI-DUST AND CONDITIONER EFFECTIVENESS
TECHNICAL FIELD OF THE INVENTION The present invention is in relation to shampoo compositions that provide a superior combination of anti-dandruff and conditioning efficacy. These compositions contain anionic surfactants, conditioning agents, anti-dandruff agents, cationic polymers and water. These anti-dandruff shampoo compositions show (a) at least a certain value of the bioavailability / coverage index-r (b) less than or equal to a certain value of the first conditioning index, (c) at least a certain value of the index of the second conditioning and (d) at least a certain value of the minimum inhibitory concentration index, as defined in this invention.
BACKGROUND OF THE INVENTION j Shampoo compositions comprising various combinations of detersive surfactants and conditioning agents, especially silicone conditioning agents, are known in the technical field and are commercially available. It has been found that many of these compositions provide excellent hair cleansing and a conditioning function. For example, Pro-Vitamin Conditioner-in-One Pantene® Shampoo Plus formulas containing anionic surfactants, a cationic polymer and silicone conditioning agents provide excellent cleansing, conditioning and benefits of a pleasant hair feel in every application . Anti-dandruff shampoos are also well known in the technical field and are also commercially available. Anti-dandruff shampoos typically incorporate anti-dandruff active ingredients and detersive surfactants. Preferred types of anti-dandruff agents are crystalline particulate antidandruff agents, such as sulfur, selenium disulfide and heavy metal salts of pyridinethione. Soluble antidandruff agents, such as ketoconazole, are also known in the technical field. Anti-dandruff shampoos that also provide conditioning benefits are also known in the technical field. For example, U.S. Patent No. 5,624,666 exemplifies and claims shampoo compositions containing anionic surfactants, cationic polymers and zinc pyridinethione as an antidandruff agent. U.S. Patent No. 5,624,666 teaches that conditioning agents such as silicone fluids can be optionally incorporated into the compositions themselves. Head & Dandruff Shampoo and Conditioner Shoulders® Dandruff is an example of a commercialized product that provides both anti-dandruff and conditioner benefits in hair shampoo applications. However, some consumers want a shampoo that provides a superior combination of anti-dandruff efficacy and conditioning performance against the products currently marketed. This superior combination of efficiency and conditioning can be difficult to achieve. For example, one way of achieving excellent conditioning benefits is the use of a fairly high level of a cationic polymer in the shampoo composition. However, the use of high levels of cationic polymers can affect the characteristics of the coacervate formed between the cationic polymer and the anionic surfactant in a manner that negatively impacts the deposition of the antidandruff active ingredients on the hair and scalp. In this way, it has hitherto been thought that the level of cationic polymers must be balanced to provide the best antidandruff conditioning and efficacy balance. Also by way of example, it was previously thought that excellent anti-dandruff efficacy could be achieved by using a coacervate to deposit antidandruff active ingredients on the hair and scalp. Unfortunately, the use of coacervates to deposit antidandruff active ingredients on the hair or scalp can negatively affect the conditioning, specifically the sensation of clean hair. In order to achieve a good conditioning, the level of the anti-dandruff agent could be reduced, resulting in a good conditioning, but with less than optimal anti-dandruff efficacy. Applicants have now discovered, however, that, surprisingly, the bioavailability and coverage of the antidandruff active ingredients are much more predictable in their efficacy than the deposition of the active ingredients on the hair or scalp. In fact, the applicants have found that, in some cases, even when the antidandruff active ingredients are very well deposited on the hair and scalp, an acceptable anti-dandruff efficacy is not achieved. Conversely, good antidandruff efficacy could be achieved in situations where the antidandruff active ingredients have a good coverage and are highly bioavailable, but not deposited superiorly on the hair or scalp. Thus, for a shampoo composition to provide a superior combination of anti-dandruff efficacy and conditioning compared to known shampoo compositions, it must meet certain criteria with respect to bioavailability and coverage, but it must not necessarily have the ability to deposit the shampoos. anti-dandruff active ingredients in top grade on the hair or scalp. Applicants have found that four requirements must be met to provide shampoo compositions that provide a superior combination of efficacy and conditioning. In particular, (1) the bioavailability and coverage of the antidandruff active ingredients are important factors for anti-dandruff efficacy; (2) the combing ability of damp hair and (3) the feeling of clean hair are important factors in consumer perception of well-conditioned hair; and (4) the inherent ability of the antidandruff active ingredients to inhibit the growth of microorganisms has an impact on the anti-dandruff efficacy as well as on the overall consumer acceptance of the shampoo product. Compliance with the criteria required for a given shampoo composition depends on a number of aspects of the shampoo formulation including,
P1383 example, the level and type of cationic polymer used in the composition, the type of anti-dandruff agent used, the amount of anionic surfactant used, the level and type of polyalkylene glycol used, if used, and the rheological characteristics of the coacervate. It is an object of the present invention to provide shampoo compositions, which provide a superior combination of efficacy. anti-dandruff and conditioning. It is also an object of the present invention to provide a method for cleaning and conditioning hair. These and other objects will be readily apparent in the detailed description below.
SUMMARY OF THE INVENTION The present invention relates to a shampoo composition comprising: (A) of between about 5% and 50% by weight, of an anionic surfactant; (B) of approximately between 0.01% and 10% by weight, of a non-volatile conditioning agent; (C) of approximately between 0.1% and 4%, by weight of an antidandruff agent; (D) of approximately between 0.02% and 5%, by weight of at least one cationic polymer; and (E) water. The composition: (A) has a bioavailability / coverage index value, as defined in this invention, of at least
P1383 about 1.25; (B) has a value of the first conditioning index, as defined in this invention, less than or equal to about 1.0; (C) has a value of the second conditioning index, as defined in this invention, of at least about 1.5; and (D) has a minimum inhibitory concentration index value, as defined in this invention, of at least about 0.125. The present invention furthermore relates to a method for providing anti-dandruff efficacy and hair conditioning comprising the application to the hair and scalp of an amount of the composition described above that is effective to provide those benefits.
DETAILED DESCRIPTION OF THE INVENTION The shampoo compositions of the present invention provide a superior combination of anti-dandruff efficacy and conditioning. These antidandruff conditioning shampoo compositions may comprise, consist of or consist essentially of the essential elements and limitations of the invention described herein, as well as of any additional or optional ingredient, component or limitation described in this invention. In particular, these compositions comprise anionic surfactants, conditioning agents, anti-dandruff agents, cationic polymers, and water. More particularly, these compositions exhibit certain characteristics that are measured by means of four indices, defined in this invention. The shampoo compositions of the present invention have a bioavailability / coverage index value of at least about 1.25, preferably at least about 1.5, more preferably at least about 2.0. This index is indicative of anti-dandruff efficacy. Generally, the greater the value of the composition index, the better is its anti-dandruff efficacy, due to an antidandruff agent with greater bioavailability, and to an increased coverage of the antidandruff agent, or both. Applicants have discovered that, surprisingly, the bioavailability and coverage of the anti-dandruff active ingredients are much more predictable in their efficacy than the deposition of the active ingredients on the hair or scalp. In fact, the applicants have found that, in some cases, even when the antidandruff active ingredients are deposited very well on the hair and scalp, an acceptable anti-dandruff efficacy is not achieved. Conversely, good anti-dandruff efficacy could be achieved in situations where the anti-dandruff active ingredients have good coverage and high bioavailability, but do not deposit superiorly on the hair or scalp. Applicants believe that there are several ways to increase the bioavailability of the anti-dandruff active ingredients. For example, the composition can be formulated (as will be described below) in such a way that the antidandruff active ingredients are present on the surface of the coacervate (for example, fragilely associated with the coacervate) instead of being integrated into or encapsulated by the coacervate. Another way of increasing the bioavailability of the antidandruff active ingredients is to formulate the composition (as will be described below) in such a way that the coacervate is dispersible or fluid (rather than elastic) to increase the bioavailability of any antidandruff active ingredients that are integrated inside or encapsulated by the coacervate. The shampoo compositions of the present invention have a first conditioning index value less than or equal to about 1.0, preferably less than or equal to about 0.96, more preferably less than or equal to about 0.94, preferably superlative less than or equal to about 0.91. This index is indicative of conditioning, as consumers understood the composition of the shampoo. Generally, the lower the value of the composition index, the better is its conditioning capacity, due to an easier hairstyle and a lesser amount of wet tangled hair. The shampoo compositions of the present invention have a second conditioning index value of at least about 1.5, preferably at least about 1.75, more preferably at least about 2.0, even more preferably at least about 2.25, preferably superlative of at least about 2.5. This index is indicative of conditioning, as consumers understood the composition of the shampoo. Generally, the higher the index value of the composition, the better is its conditioning capacity, due to an increased feeling of clean hair. The shampoo compositions of the present invention have a minimum inhibitory concentration index value of at least about 0.125, preferably at least about 0.25, more preferably at least about 0.5. This index is indicative of antidandruff efficacy. Generally, the higher the value of the composition index, the more effective its anti-dandruff efficacy, due to a
P1383 increase in the inherent capacity of the antidandruff agent to inhibit the growth of microorganisms. The components, including those that could be optionally added, of the shampoo compositions of the present invention, as well as the methods for the preparation and methods for their use, are described in detail below. Also, the methods to evaluate the four indices are described in detail.
I. Components The antidandruff shampoo conditioner compositions of the present invention comprise an anionic surfactant, a conditioning agent, an antidandruff agent, a cationic polymer and water. Each of these ingredients is described in detail below.
A. Anionic surfactant The compositions of the antidandruff conditioning shampoo of the present invention comprise approximately between 5% and 50% by weight of the composition, preferably approximately between 8% and 30%, more preferably approximately between 10% and 25%, preferably superlative between about 12% and 18%, of an anionic detersive surfactant component suitable for application to hair or skin. It is believed that the
P1383 anionic detersive surfactant provides the composition with a cleaning and foaming function. Additionally, the anionic detersive surfactant forms a coacervate, in aqueous dilution, with the cationic polymer component (described below) of the present invention. It is believed that this coacervate is important to provide the efficacy and conditioning benefits described in this invention. The anionic detersive surfactant component may comprise an anionic detersive surfactant, a zwitterionic or an amphoteric detersive surfactant having a bound moiety that is anionic, at the pH of the composition, or a combination thereof; preferably an anionic detersive surfactant. These surfactants must be physically and chemically compatible with the essential components in this invention described, and must not, on the other hand, unduly deteriorate the stability of the product, its aesthetics or performance. Some examples of anionic detersive surfactants that can be suitably used in the shampoo compositions of this invention are included, in non-exclusive form: sulfates, sulfonates, sarcosinates and sarcosine derivatives.
1. Sulfates Anionic detersive surfactants for use in the anti-dandruff conditioner shampoo compositions of the present invention are the alkyl and alkyl ether sulfates. These surfactants have the respective formula ROS03M and R (C2H40) xOS03M, wherein R is an alkyl or alkenyl having about 8 to 18 carbon atoms, x is an integer having a value from 1 to 10 and M is an cation selected from the group consisting of covalently attached moieties electropositive (for example ammonium), alkanolamines (for example triethanolamine), monovalent metals (for example sodium or potassium), polyvalent metal cations (for example magnesium and calcium) and mixtures of these. The cation M must be selected such that the anionic detersive surfactant component is soluble in water. The solubility of the surfactant will depend on the anionic detersive surfactants in particular and the cations chosen. Preferably, R has about 8 to 18 carbon atoms, more preferably about 10 to 16 carbon atoms, preferably about 12 to 14 carbon atoms, in both the alkyl and the alkyl ether sulfate. Alkyl ether sulfates are typically made as condensation products of ethylene oxide and monohydric alcohols having approximately 8 to 24 atoms
P1383 carbon The alcohols may be synthetic or derived from fats, for example, coconut oil, palm kernel oil, and tallow. Lauryl alcohol and straight chain alcohols derived from coconut oil or palm kernel oil are preferred. These alcohols are reacted with 0 to about 10, preferably approximately between 2 and 5, preferably superlative with approximately 3, moles of ethylene oxide. The resulting mixture of molecular species will have, for example, an average of 3 moles of ethylene oxide per mole of alcohol, and is sulfated and neutralized. Non-limiting examples of alkyl ether sulfates may be used in the shampoo compositions of the present invention, including sodium and ammonium salts of alkyl triethylene glycol coconut ether sulfate, alkyl triethylene glycol sulfate tallow ether and tallow alkyl hexoxyethylene sulfate . Preferred alkyl ether sulfates are those comprising a mixture of individual components, wherein the compounds of the mixture have an alkyl chain length of about 10 to 16 carbon atoms and an average degree of ethoxylation of between about 1 and 4 moles of ethylene oxide. Some specific examples of preferred alkyl sulfates include, in non-exclusive form: ammonium lauryl sulfate, ammonium cocoyl sulfate, potassium lauryl sulfate, potassium cocoyl sulfate, sodium lauryl sulfate, sodium cocoyl sulfate, monoethanolamine lauryl sulfate, monoethanolamine cocoyl sulfate, diethanolamine lauryl sulfate, triethanolamine lauryl sulfate, triethylamine lauryl sulfate and combinations thereof. Especially preferred is ammonium lauryl sulfate. Some specific examples of preferred alkyl ether sulfates include, in non-exclusive form: ammonium laureth sulfate, potassium laureth sulfate, sodium laureth sulfate, monoethanolamine laureth sulfate, diethanolamine laureth sulfate, triethanolamine laureth sulfate, triethylamine laureth sulfate and its combinations. Especially preferred is ammonium laureth sulfate. Yet another class of sulfate surfactants suitable for use in the anti-dandruff conditioning shampoos of the present invention are the glyceride sulfates, an example includes, in non-exclusive form, sodium laurico-sulfate monoglyceride.
2. Sulfonates are also suitable for use in the antidandruff conditioning shampoos of the present invention those anionic detersive surfactants known as
P1383 olefin sulfonates. As used in this invention, the term "olefin sulfonates" refers to compounds that can be produced by sulfonation of α-olefins by unsynchronized sulfur trioxide, followed by neutralization of the acid reaction mixture under such that any sufonates that would have formed in the reaction will hydrolyze to provide the corresponding hydroxy-alkane sulfonates. The sulfur trioxide may be liquid or gas, and usually, but not necessarily, diluted by inert diluents, for example by liquid S0, chlorinated hydrocarbons or the like, when used in the liquid form, or by means of air, nitrogen, gaseous S0, or the like, when used in gaseous form. The α-olefins from which the olefin sulfonates are derived are mono-olefins having about 10 to 24 carbon atoms, preferably about 12 to 16 carbon atoms. Preferably, they are straight chain olefins. In addition to the true alkene sulfonates and a proportion of hydroxyalkane sulphonates, the olefin sulfonates may contain minor amounts of other materials, such as alkene disulfonates depending on the reaction conditions, the proportion of reactants, the nature of the
P1383 starting olefins and impurities in the raw material of olefins and side reactions during the sulphonation process. A non-limiting example of a mixture of α-olefin sulfonate is described in U.S. Patent No. 3,332,880, the disclosure of which is incorporated herein by reference. Another class of sulfonates suitable for use in the antidandruff conditioning shampoo compositions of the present invention are those anionic detersive surfactants known as β-alkoxyalkane sulfonates. These surfactants conform to the general formula (I):
wherein R 1 is a straight chain alkyl group having from about 6 to about 20 carbon atoms, R 2 is a lower alkyl group having about 1 to 3 carbon atoms, preferably 1 carbon atom and M is a cation soluble in water, as those described above. Still other sulfonates suitable for use in the antidandruff conditioning shampoo compositions of the present invention are those
Pl383 anionic detersive surfactants known as alkyl aryl sulfonates. Non-limiting examples of alkyl aryl sulfonates include sodium tridecylbenzene sulfonate, sodium dodecylbenzene sulfonate and combinations thereof. Other sulfonates suitable for use in the anti-dandruff conditioning shampoos of the present invention are the water-soluble salts of the organic products of the reaction with sulfuric acid which form the formula [R1-S03-M] wherein R1 is a radical of a hydrocarbon aliphatic straight or branched chain, saturated, having about 8 to 24 carbon atoms, preferably about 10 to 18 carbon atoms; and M is the cation described above. Non-limiting examples of these anionic detersive surfactants are the salts of an organic reaction product of sulfuric acid with a hydrocarbon of the methane series, including iso-, neo-, and n-paraffins and a sulfonant, example, S03, H2S04, obtained according to the known sulfonation methods. Within the sulfonation methods may include bleaching and hydrolysis. The salts preferably have about 8 to 24 carbon atoms; more preferably about 12 to 18 carbon atoms. Preferred are sulfonated, alkali metal, and ammonium C? 0_C? 8 n-paraffins.
PL383 Still other sulfonates suitable for use in the anti-dandruff shampoo conditioner compositions of the present invention are the reaction products of fatty acids, which are esterified with isethionic acid and subsequently neutralized with sodium hydroxide. Preferred fatty acids are those derived from coconut oil or palm kernel oil. Also suitable are the sodium or potassium salts of fatty acid amides of methyl tauride in which the fatty acids are derived from coconut oil or palm kernel oil. Other similar anionic surfactants are described in U.S. Patent No. 2,486,921; U.S. Patent No. 2,486,922; and U.S. Patent No. 2,396,278, the disclosures of which are incorporated herein by reference. Other sulfonates suitable for use in the anti-dandruff shampoo conditioner compositions of the present invention are succinates, examples of which include, in a non-exclusive manner, disodium N-octadecylsulfosuccinate, disodium lauryl sulfosuccinate, diammonium lauryl sulfosuccinate, N- (1, 2-) dicarboxyethyl) -N-octadecylsulfosuccinnate disodium, diamyl ester of sodium sulfosuccinic acid, sodium dihexyl ester of sulfosuccinic acid, sodium dioctyl ester of sulfosuccinic acid and combinations thereof.
P1383 3. Sarcosinates and sarcosine derivatives Also suitable for use in the antidandruff conditioning shampoos of the present invention are those anionic detersive surfactants known as sarcosinates and sarcosine derivatives. Sarcosinates are derived from sarcosines and N-methyl glycine, acylated with a fatty acid chloride. They conform to the general formula (II):
OR
II R-.C-N ~ CH2-C-0-O-X CH3
wherein RCO- is a fatty acid radical and wherein X is either hydrogen (in the form of an acid) or a cationic species, such as for example Na + or TEA + (salt form). Non-limiting examples of sarcosinates and sarcosine derivatives include: sodium lauryl sarcosinate, lauroyl sarcosinate, cocoyl sarcosinate and combinations thereof. The preferred sarcosinate is sodium lauryl sarcosinate.
B. Conditioner The anti-dandruff conditioning shampoo compositions of the present invention comprise
P1383 approximately between 0.01% and 10%, by weight of the composition, preferably approximately between 0.1% and 8%, more preferably approximately between 0.1% and 5%, preferably superlative approximately between 0.2% and 3.5%, of an agent Conditioner suitable to be applied to hair or skin. It is believed that the conditioning agent provides improved conditioning benefits to the hair, particularly the improved feeling of clean hair and the feeling of a wet rinse. The conditioning agent comprises a water-insoluble, water-dispersible, non-volatile liquid, which forms emulsified liquid particles, or which are solubilized by means of the mycelia of the surfactant, in the anionic detersive surfactant component (described above). The conditioning agents suitable for use in the shampoo composition are those conditioning agents generally characterized as silicones
(for example silicone oils, cationic silicones, silicone gums, high refractive index silicones and silicone resins), organic conditioning oils (for example hydrocarbon oils, polyolefins and fatty esters) or their combinations, or those conditioning agents which , otherwise, form liquid particles, dispersed in the matrix
P1383 aqueous surfactant in there. These conditioning agents should be physically and chemically compatible with the essential components of the composition and should not, on the other hand, unduly deteriorate the stability of the product, its aesthetics or its operation. The concentration of the conditioning agent in the shampoo composition should be sufficient to provide the desired conditioning benefits, as will be apparent to those who dominate the technical field. That concentration can vary depending on the conditioning agent, the conditioning performance desired, the average size of the conditioning agent particles, the type and concentration of other components and other similar factors.
1. Silicones The conditioning agent of the anti-dandruff shampoo conditioner compositions of the present invention is preferably an insoluble silicone conditioning agent. The particles of the silicone conditioning agent may comprise volatile silicone, non-volatile silicone, or combinations thereof. Preferably the non-volatile silicone conditioning agents. In case it is
P1383 present volatile silicones, will typically be incidental to use as a solvent or vehicle for commercially available forms of non-volatile silicone material ingredients, such as gums and resins. The particles of the silicone conditioning agent may comprise a fluid silicone conditioning agent and may also comprise other ingredients, such as silicone resin, to increase the efficiency of the deposition of the silicone fluid or to increase the shine of the hair (especially when silicone conditioning agents (e.g. highly phenylated silicones) of high refractive index (eg, above about 1.46) are used.The concentration of the silicone conditioning agent typically falls wi the range of between about 0.01% and 10% by weight of the composition, preferably between about 0.1% and 8%, more preferably between about 0.1% and 5%, preferably superlative between about 0.2% and 3% Non-limiting examples of suitable silicone conditioning agents and optional suspension agents for the silicone are described in the patent and the re-issued United States No. 34,584, United States Patent No. 5,104,646, and United States Patent No. 5,106,609, the descriptions of which are
P1383 are incorporated herein by reference. The silicone conditioning agents to be used in the antidandruff conditioning shampoo compositions of the present invention preferably have a viscosity, measured at 25 ° C, of between about 20 and 2,000,000 centistokescentistokes, more preferably about between 1,000 and 1,800,000 centistokes, even more preferably from about 50,000 to 1,500,000 centistokes, with superlative preference of approximately between 100,000 and 1,500,000 centistokes. The dispersed particles of the silicone conditioning agent typically have an average particle diameter that is in the range of about 0.01 μm to 50 μm. For the application of small particles to the hair, the average diameter of the particles typically lies wi the range of approximately between 0.01 μm and 4 μm, preferably approximately between 0.01 μm and 2 μm, more preferably approximately between 0.01 μm and 0.5 μm. μm. For the application of larger particles to the hair, the average particle diameter is typically in the range of approximately 4 μm to 50 μm, preferably approximately 6 μm to 30 μm, more preferably approximately 9 μm and 20 μm, preferably superlative of approximately
P1383 between 12 μm and 18 μm. Conditioning agents having an average particle size of less than about 5 μm can be deposited more efficiently on the hair. It is believed that the small size particles of the conditioning agent are contained wi the coacervate which is formed between the anionic surfactant component (described above) and the cationic polymer component (described below), in dilution of the shampoo. The background of the matter about silicones including the sections in which silicone fluids, resins and gums were analyzed, as well as silicone processing, are found in Encyclopedia of Polymer Science and Engineering-, vol. 15, 2d ed. , pp 204-308, John Wiley & Sons, Inc. (1989), incorporated herein by reference. i. Silicone oils Silicone fluids include silicone oils, which are flowable silicone materials having a viscosity, measured at 25 ° C, less than 1,000,000 centistokes, preferably of about 5 centistokes 1,000,000 centistokes, more preferably between about 10 centistokes and 100,000 centistokes. Silicone oils suitable for use in conditioning shampoo compositions
P1383 antidandruff of the present invention include polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes, polyether siloxane copolymers and combinations thereof. Other insoluble and non-volatile silicone fluids having hair conditioning properties can also be used. The silicone oils include polyalkyl or polyaryl siloxanes which form the following formula (III):
wherein R is aliphatic, preferably alkyl or alkenyl, or aryl, R may be substituted or unsubstituted and x is an integer from 1 to about 8,000. Unsubstituted R groups for use in the anti-dandruff shampoo conditioner compositions of the present invention include, in non-exclusive form: alkoxy, aryloxy, alkaryl, arylalkyl, arylalkenyl, alkylamino, and aliphatic and aryl substituted with ether, substituted with hydroxyl and substituted with halogen. Suitable R groups also include cationic amines and quaternary ammonium groups.
P1383 The aliphatic or substituted aryl groups in the siloxane chain may have any structure so long as the resulting silicones remain fluid at room temperature, are hydrophobic and are not irritating, toxic or otherwise detrimental when applied to hair, are compatible with the other components of the shampoo compositions, are chemically stable under normal conditions of use and storage, are insoluble in the shampoo compositions described herein and are capable of being deposited on the hair and conditioning it. The two R groups on the silicon atom of each monomer unit may represent the same or different groups. Preferably, the two R groups represent the same group. Preferred alkyl and alkenyl substituents are alkyls and alkenyls of C.-C5, more preferably C1-C1, preferably superlative of C ^ -. The aliphatic portions of other alkyl-, alkenyl- or alkynyl-containing groups (such as, for example, alkoxy, alkaryl, and alkamino) can be straight or branched chains and preferably have from one to five carbon atoms, more preferably from one to four carbon atoms, still more preferably from one to three carbon atoms, preferably superlative from one to two carbon atoms. How I know
Pl383 4 28
previously discussed, the R substituents may also contain amino functionalities (eg alkamino groups), which may be primary, secondary or tertiary amines or quaternary ammonium. These include mono-, di- and trialkylamino and alkoxyamino groups, in which the chain length of the aliphatic part is preferably as described above. The R substituents may also be substituted with other groups, such as halogens (for example chlorine, fluorine and bromine), halogenated aliphatic or aryl groups and hydroxy (for example hydroxy-substituted aliphatic groups) and combinations thereof. Suitable halogenated R groups could include, for example, trihalogenated alkyl groups (preferably tri-fluoro) such as -R ^ Fj, where R1 is a Cj-C alkyl ... An example of these polysiloxanes includes, in the form non-exclusive, polymethyl 3,3, 3-trifluoropropylsiloxane. Suitable R groups for use in the antidandruff shampoo conditioner compositions of the present invention include, in non-exclusive form, methyl, ethyl, propylphenyl, methylphenyl and phenylmethyl. Specific non-limiting examples of preferred silicones include: polydimethylsiloxane, polydiethylsiloxane, and polymethylphenylsiloxane. Polydimethylsiloxane is especially preferred.
P1383 Other suitable R groups include: methyl, methoxy, ethoxy, propoxy, and aryloxy. The three R groups in the final silicone capsules may represent the same or different groups. The non-volatile polyalkylsiloxane fluids that can be used include, for example, low molecular weight polydimethylsiloxanes. These siloxanes are commercially available, for example, in General Electric Company as Viscasil R and SF series, and in Dow Corning in the Dow Corning 200 series. The polyalkylaryl siloxane fluids that may be used, also include, for example, polymethylphenylsiloxanes. These siloxanes are commercially available, for example, in General Electric Company as SF 1075 methylphenyl fluid or in Dow Corning as cosmetic grade fluid 556. Polyethersiloxane copolymers that can be used include, for example, a polydimethylsiloxane modified with Polypropylene
(e.g., Dow Corning DC-1248) although ethylene oxide or mixtures of ethylene oxide and propylene oxide can also be used. The concentrations of ethylene oxide and polypropylene oxide should be low enough to prevent solubility in water and in the compositions described in this invention. Silicones substituted with alkylamino
P1383 suitable for use in the anti-dandruff conditioning shampoo compositions of the present invention include, in non-exclusive form, those that conform to the following general formula (IV):
where x and y are integers. This polymer is also known as "amodimethicone."
ii. Cationic Silicones Cationic silicone fluids suitable for use in the antidandruff conditioning shampoo compositions of the present invention include, but are not limited to, those conforming to the general formula (V):
(R1) aG3_aSi - (- OSiG2) n (-OSiGb (R1) 2-b) m-0-SiG3_a (R1) a
wherein G is hydrogen, phenyl, hydroxy, or an alkyl of
P1383 Ci-Ca, preferably methyl; a indicates 0 or an integer with a value that is from 1 to 3, preferably 0; b is 0 or 1, preferably 1; n is a number from 0 to 1,999, preferably from 49 to 149; m is an integer from 1 to 2,000, preferably
'from 1 to 10; the sum of n and m is a number from 1 to 2,000, preferably from 50 to 150; Ri is a monovalent radical that conforms to the general formula
CqH2qL, where q is an integer that has a value that is from 2 to 8 and L is selected from the following groups: -N (R2) CH2-CH2-N (R2) 2 -N (R2) 2 - N (R2) 3A ~ -N (R2) CH2-CH2-NR2H2A- wherein R is selected from the group consisting of hydrogen, phenyl, benzyl, or a saturated hydrocarbon radical, preferably an alkyl radical containing from about 1 to about about 20 carbon atoms, and A "indicates a halide ion A particularly preferred cationic silicone corresponding to formula (V) is the polymer known as" trimethylsilylamodimethicone ", which is shown below in formula (VI):
P1383 m
Other cationic silicone polymers that can be used in the anti-dandruff shampoo conditioner compositions of the present invention are represented by the general formula (VII):
wherein R denotes a monovalent hydrocarbon radical having from 1 to 18 carbon atoms, preferably an alkyl or alkenyl radical, such as methyl; R4 denotes a hydrocarbon radical, preferably an alkylene radical of C? _C? S or an alkyleneoxy radical of Cio-Cia, more preferably an alkylenoxy radical of C?
Pl383 Cs; Q ~ is a halide ion, preferably chloride; r indicates an average statistical value that is between 2 and 20, preferably between 2 and 8; s indicates a statistical value that is between 20 and 200, preferably between 20 and 50. A polymer of this especially preferred kind is known under the name UCARE SILICONE ALE 56 ™, commercially available from Union Carbide.
iii. Silicone Gums Other silicone fluids that may be suitable for use in the anti-dandruff shampoo conditioner compositions of the present invention are insoluble silicone gums. These gums are polyorganosiloxane materials that have a viscosity, measured at 25 ° C, greater than or equal to 1,000,000 centistokes. Silicone gums are described in U.S. Patent No. 4,152,416; Noli and Walter, Chemistry and Technology of Silicones, New York: Academic Press (1968); and in General Electric Silicone Rubber Product Data Sheets SE 30, SE 33, SE 54 and SE 76, all of these described references are incorporated herein by reference. Silicone gums will typically have an average mass molecular weight above about 200,000, preferably between about 200,000 and 1,000,000. Specific non-limiting examples of silicone gums
P1383 for use in the antidandruff shampoo conditioner compositions of the present invention include polydimethylsiloxane, (polydimethylsiloxane) copolymers
(methylvinylsiloxane), copolymers of poly (di-ethylsiloxane) (diphenylsiloxane) (methylvinylsiloxane) and combinations thereof.
iv. High Refractive Index Silicones Another category of insoluble, non-volatile, silicone fluid conditioning agents which are suitable for use in the anti-dandruff conditioning shampoo compositions of the present invention are the silicones known as "high refractive index silicones," which have a refractive index of at least about 1.46, preferably at least about 1.48, more preferably at least about 1.52, preferably superlative at least about 1.55. The refractive index of the polysiloxane fluid will generally be less than about 1.70, typically less than about 1.60. Within this context, the "fluid" polysiloxane includes both oils and gums. The polysiloxane fluid of suitable high refractive index includes the fluids represented by the general formula (III) above, as well as the cyclic polysiloxanes, such as those represented
P1383 by the following formula (VIII):
wherein R is as defined above and n is an approximate number between 3 and 7, preferably between about 3 and 5. High refractive index polysiloxane fluids contain a sufficient amount of substituents R containing aryl to increase the index of refraction to the desired level, which is described above. Additionally, R and n must be selected in such a way that the material is non-volatile. The aryl-containing substituents include those containing five or six membered aryl rings, alicyclic and heterocyclic, and substituents containing fused five or six membered rings. The aryl rings themselves may be substituted or unsubstituted. Substituents include aliphatic substituents and may also include alkoxy substituents, acyl substituents, ketones, halogens (e.g., Cl and Br), amines, and the like. Examples of aryl-containing groups include, in non-exclusive form, weirs
P1383 substituted and unsubstituted, such as phenyl and phenyl derivatives, for example phenyls with C1-C5 alkyl or alkenyl substituents. Specific non-limiting examples include: allylphenyl, methylphenyl and ethylphenyl, vinylphenyls (for example styrenyl) and phenylalkynes (for example C2-C4 phenylalkynes). Heterocyclic aryl groups include, in non-exclusive form, substitutents derived from furan, imidazole, pyrrole, pyridine and the like. Examples of fused aryl ring substituents include, in non-exclusive form, naphthalene, coumarin, and purine. Generally, high refractive index polysiloxane fluids will have a degree of aryl containing substituents of at least about 15%, preferably at least about 20%, more preferably at least about 25%, even more preferably at least about 35%, preferably superlative at least about 50%. Typically, the degree of aryl substitution will be less than about 90%, more generally less than about 85%, preferably about 55% to about 80%. These high refractive index polysiloxane fluids are also characterized by relatively high surface tensions as a result of their
P1383 substitution with aryl. Generally, the polysiloxane fluids will have a surface tension of at least about 24 dynes / cm2, typically at least about 27 dynes / cm2. The surface tension, for the purposes of this invention, is measured by a Nouy ring tensiometer according to Dow Corning Corporate Test Method CTM 0461 (November 23, 1971). Changes in surface tension can be measured according to the method of the above test or in accordance with ASTM Method D 1331. Preferred high refractive index polysiloxane fluids have a combination of phenyl substituents or phenyl derivatives (with superlative preference, phenyl), with alkyl substituents, preferably C? -C alkyl (preferably superlative, methyl), hydroxy or C? -C-amino alkyl (especially -R1NHR2NH2 wherein each R1 and R2, independently, is an alkyl) , alkenyl and / or C1-C3 alkoxy). High refractive index polysiloxanes are commercially available from Dow Corning, Huís America and General Electric. When the high refractive index silicones are used in the anti-dandruff shampoo conditioner compositions of the present invention, they are preferably used in solution with a diffusing agent, such as a silicone resin or a surfactant, for the purpose of reducing stress surface in an amount sufficient to increase diffusion and therefore increase the gloss (after drying) of the hair treated with the composition. Generally, a sufficient amount of diffusing agent is used to reduce the surface tension of the polysiloxane fluid of high refractive index by at least about 5%, preferably at least about 10%, more preferably at least about 15%, even with greater preference at least about 20%, preferably superlative at least about 25%. Reductions in the surface tension of the polysiloxane fluid / diffusing agent mixture can improve the shine of the hair. Also, the diffusing agent will preferably reduce the surface tension by at least about 2 dynes / cm 2, preferably at least about 3 dynes / cm 2, still more preferably at least about 4 dynes / cm 2, preferably superlative at least about 5 dynes / cm2. The surface tension of the mixture of the polysiloxane fluid and the diffusing agent, in the proportions present in the final product, is preferably less than or equal to about 30 dynes / cm 2, more preferably
P1383 less than or equal to approximately 28 dynes / cm2, preferably superlative less than or equal to approximately 25 dynes / cm2. Typically, the surface tension will be in the range of about 15 dynes / cm2 to 30 dynes / cm2, more typically about 18 dynes / cm2 to 28 dynes / cm2, and more generally, about 20 dynes / cm2 and 25 dynes / cm2. The weight ratio of highly arylated polysiloxane fluid to the diffusing agent will generally be between about 1000: 1 and 1: 1, preferably between about 100: 1 and 2: 1, more preferably about between 50: 1 and 2 : 1, preferably superlative approximately between 25: 1 and 2: 1. When fluorinated surfactants, particularly highly-arylated polysiloxane fluids are used to the diffusing agent, the particularly high ratios of polysiloxane: the diffusing agent due to the effectiveness of these surfactants can be effective. In this way, it is contemplated that ratios significantly above 1000: 1 can be used. Suitable silicone fluids for use in the antidandruff conditioning shampoo compositions of the present invention are disclosed in U.S. Patent No. 2,826,551, U.S. Patent No. 3,964,500, U.S. Pat. No.
4,364,837, British Patent No. 849,433, and Silicon Compounds distributed by Petrarch Systems, Inc. (1984), all of which are incorporated herein by reference.
v. Silicone Resins Silicone resins can be included in the silicone conditioning agent of the anti-dandruff shampoo conditioner compositions of the present invention. These resins are highly crosslinked polymeric siloxane systems. Crosslinking is introduced through the incorporation of trifunctional and tetrafunctional silanes with monofunctional or difunctional silanes, or both, during the manufacture of the silicone resin. As understood by those who master the technical field, the degree of crosslinking that is required in order to result in a silicone resin will vary according to the specific silane units incorporated in the silicone resin. Generally, silicone materials having a sufficient level of trifunctional and tetrafunctional siloxane monomer units (and, therefore, a sufficient level of crosslinking) so that they dry to produce a rigid or hard film, are considered to be silicone resins. The ratio of oxygen atoms to atoms of
P1383 silicon is an indication of the level of crosslinking of a particular silicone material. The silicone resins suitable for use in the antidandruff shampoo conditioner compositions of the present invention generally have at least about 1.1 oxygen atoms per silicon atom. Preferably, the ratio of oxygen atoms to silicon atoms is at least about 1.2: 1.0. The silanes used in the manufacture of silicone resins include, in a non-exclusive manner, monomethyl-, dimethyl-, trimethyl-, monophenyl-, diphenyl-, methylphenyl-, monovinyl- and methylvinyl-chlorosilanes and tetrachlorosilanes, the silanes being substituted with methyl the most commonly used. Preferred resins are commercially available from General Electric as GE SS4230 and GE SS4267. Commercially available silicone resins are generally supplied in dissolved form in a volatile or non-volatile low viscosity silicone fluid. The silicone resins to be used in this invention should be supplied and incorporated into the present dissolved compositions in such a manner, as will be apparent to those who dominate the technical field. Silicone materials and silicone resins in particular, can be conveniently identified according to a naming system
P1383 shorthand known by those who dominate the technical field as "MDTQ" nomenclature. Under this system, the silicone is described according to the presence of several units of the siloxane monomer which constitute the silicone. Briefly, the symbol M denotes the monofunctional unit (CH3) 3SiO0.s; D denotes the difunctional unit (CH3) 2SiO; T denotes the trifunctional unit (CH3) SiO? .5; and Q denotes the quadri- or tetrafunctional unit Si0. The premiums of the unit symbols (for example M ", D", T ", and Q ') denote non-methyl substituents and must be defined specifically for each case Typical alternative substituents include, in non-exclusive form, such groups such as vinyls, phenyls, amines, hydroxyls and the like The molar ratios of the various units, both in terms of subscripts of the symbols that indicate the total number of each type of unit in the silicone (or an average thereof) or as Specifically stated ratios in combination with molecular weight complete the description of the silicone material under the MDTQ system, relative higher molar amounts of T, Q, T 'and / or Q' to D, D 'M and / or M' in A silicone resin is indicative of higher levels of crosslinking As discussed above, however, the overall level of crosslinking can also be indicated by the reaction of oxygen to silicon.
P1383 Preferred silicone resins for use in the antidandruff conditioning shampoo compositions of the present invention include, but are not limited to, the MQ, MT, MTQ, MDT and MDTQ resins. Methyl is the preferred silicone substituent. Especially preferred are the MQ silicone resins, in which the M: Q ratio is from about 0.5: 1.0 to about 1.5: 1.0 and the average molecular weight of the silicone resin is from about 1000 to about 10,000. The weight ratio of the non-volatile silicone fluid, having a refractive index below 1.46, to the silicone resin component, when used, is preferably from about 4: 1 to about 400: 1, more preferably from about 9: 1 to about 200: 1, preferably superlative from about 19: 1 to about 100: 1, particularly when the silicone fluid component is a polydimethylsiloxane fluid or a mixture of polydimethylsiloxane fluid and rubber. polydimethylsiloxane, as described above. Insofar as the silicone resin forms part of the same phase, in the compositions of this invention, the silicone fluid, i.e. the active conditioning ingredient, is
Pl383 should include the sum of fluid and resin to determine the level of conditioning agent in the composition.
2. Organic Conditioning Oils The conditioning component of the anti-dandruff shampoo conditioner compositions of the present invention may also comprise about 0.05 to 3% by weight of the composition, preferably about 0.08% to 1.5%, more preferably about 0.1%, and 1%, of at least one organic conditioning oil as the conditioning agent, either alone or in combination with other conditioning agents, such as silicones (described above). It is believed that these organic conditioning oils provide the shampoo composition with an improved conditioning function when used in combination with the essential components of the composition and in particular, when used in combination with cationic polymers (described above). Conditioner oils can add shine and luster to hair. Additionally, they can increase the pleasant feeling of dry combing and drying hair. It is believed that most, or all of these organic conditioning oils, are solubilized in the mycelia of the surfactant of the shampoo composition.
It is also believed that this solubilization within the mycelia of the surfactant contributes to improving the hair conditioning function of the shampoo compositions of this invention. Organic conditioning oils suitable for use as the conditioning agent in this invention are preferably low viscosity, insoluble in water, liquids selected from the group consisting of hydrocarbon oils, polyolefins, fatty esters and combinations thereof. The viscosity, measured at 40 ° C, of these organic conditioning oils is preferably about 1 centipoise to 200 centipoise, more preferably about 1 centipoise to 100 centipoise, preferably superlative about 2 centipoise to 50 centipoise.
i. Hydrocarbon Oils Organic conditioning hydrocarbon oils for use as conditioning agents in the anti-dandruff shampoo conditioner compositions of the present invention include, in non-exclusive form, hydrocarbon oils having at least about 10 carbon atoms, such as cyclic hydrocarbons, linear chain aliphatic hydrocarbons (saturated or unsaturated) and aliphatic hydrocarbons
P1383 branched chain (saturated or unsaturated), including polymers and their combinations. The straight chain hydrocarbon oils will preferably have from about 12 to about 19 carbon atoms. Branched chain hydrocarbon oils, including polymeric hydrocarbons, will typically contain more than 19 carbon atoms. Specific non-limiting examples of these hydrocarbon oils include paraffin oil, mineral oil, saturated and unsaturated dodecane, saturated and unsaturated tridecane, saturated and unsaturated tetradecane, saturated and unsaturated pentadeca, saturated and unsaturated hexadecane, polybutene, polydecane and combinations thereof. The branched chain isomers of these compounds, as well as the longer chain length hydrocarbons, can also be used. Some examples include highly branched, saturated or unsaturated alkanes, such as permethyl substituted isomers, for example, the isomers substituted with permethyl of hexadecane and eicosane, such as 2, 2, 4, 4, 6, 6, 8, 8-dimethyl -10-methylundecane and 2, 2, 4, 4, 6, 6-dimethyl-8-methyl-nonane, commercially available from Permetil Corporation. Hydrocarbon polymers such as polybutene and polydecane are also useful conditioning agents. A preferred hydrocarbon polymer is polybutene, as
P1383 for example the copolymer of isobutylene and butene. A commercially available material of this type is L-14 polybutene from Amoco Chemical Corporation.
ii. Polyolefins Organic conditioning oils for use in the anti-dandruff shampoo conditioner compositions of the present invention may also include liquid polyolefins, more preferably liquid poly-α-olefins, preferably superlative liquid hydrogenated poly-α-olefins. The polyolefins to be used in this invention were prepared by the polymerization of olefinic monomers from 4 to about 14 carbon atoms, preferably from about 6 to about 12 carbon atoms. Non-limiting examples of olefinic monomers to be used in the preparation of the liquid polyolefins of this invention include ethylene, propylene, 1-butene, 1-pentene, 1-hexene, 1-octene, 1-decene, 1-dodecene, 1 - tetradecene, branched chain isomers such as 4-methyl-1-pentene and combinations thereof. Effluents or feed storage of refining products containing olefins are also suitable for the preparation of liquid polyolefins. The hydrogenated α-olefin monomers
Preferred P1383s include, in non-exclusive form, 1-hexene to 1-hexadecene, 1-octene at 1-tetradecene and combinations thereof.
iii. Fatty esters Other organic conditioning oils suitable for use as a conditioning agent in the antidandruff shampoo conditioner compositions of the present invention include, in non-exclusive form, fatty esters having at least 10 carbon atoms. These fatty esters include esters with hydrocarbyl chains derived from fatty acids or alcohols (for example monoesters, esters of polyhydric alcohol and di- and tri- esters of carboxylic acid). The hydrocarbyl radicals of the fatty esters of this invention may include or have covalent linkages to other compatible functionalities, such as amide moieties and alkoxides (e.g., ethoxy or ether linkages, etc.). Suitable for use in the antidandruff conditioning shampoo compositions of the present invention are alkyl or alkenyl esters of fatty acids having aliphatic chains with about 10 to 22 carbon atoms, and alkyl or alkenyl esters of carboxylic acid and alcohol fatty acids having an aliphatic alkyl and / or alkenyl chain derived from alcohol with about 10 to 22
Pl383 carbon atoms and their combinations. Specific examples of the preferred fatty esters include, in non-exclusive form, isopropyl isostearate, hexyl laurate, isohexyl laurate, isohexyl palmitate, isopropyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stearate, decyl stearate, isopropyl isostearate, dihexyldecyl adipate, lauryl lactate, myristyl lactate, cetyl lactate, oleyl stearate, oleyl oleate, oleyl myristate, lauryl acetate, cetyl propionate and oleyl adipate. Other fatty esters suitable for use in the antidandruff conditioning shampoo compositions of the present invention are the monocarboxylic acid esters, which have the general formula R'COOR, wherein R "and R are alkyl or alkenyl radicals and the sum of carbon atoms in R 'and R is at least 10, preferably at least 20. The monocarboxylic acid esters need not necessarily contain at least one chain with at least 10 carbon atoms, rather than the total number of carbon atoms of the aliphatic chain is at least 10. Specific non-limiting examples of esters of the monocarboxylic acid include: isopropyl myristate, glycol stearate and isopropyl laurate.
P1383 Still other fatty esters suitable for use in the antidandruff conditioning shampoo compositions of the present invention are di- and trialkyl and alkenyl esters of carboxylic acids, such as esters of C4-C8 dicarboxylic acids (for example C1-C22 esters preferably Ci-Cg, succinic acid, glutaric acid, adipic acid, hexanoic acid, heptanoic acid and octanoic acid). Specific non-limiting examples of di- and trialkyl and alkenyl esters of carboxylic acids include isocetyl stearate and stearoyl, diisopropyl adipate and tristearyl citrate. Other fatty esters suitable for use in the anti-dandruff conditioning shampoo compositions of the present invention are those known as polyhydroxy alcohol esters. Polyhydroxy alcohol esters include alkylene glycol esters, such as ethylene glycol mono and di fatty esters, diethylene glycol mono and di fatty esters, polyethylene glycol mono and di fatty esters, mono and di fatty acid esters of propylene glycol, propylene glycol monooleate, propylene glycol monostearate 2000, ethoxylated propylene glycol monostearate, glyceryl mono and di fatty acid esters, polyglycerol fatty acid esters,
Pl383 ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters and fatty acid esters of sorbitan and polyoxyethylene. Other fatty acid esters suitable for use in the anti-dandruff conditioning shampoo compositions of the present invention are glycerides, including, but not limited to, mono, di and triglycerides, with preferably superfluous triglycerides. For use in the described shampoo compositions of this invention, the glycerides are preferably mono, di and tri-esters of glycerol and long-chain carboxylic acids, such as for example carboxylic acids of C? 0-C22- A variety of these types of materials can be obtained from vegetable and animal fats and oils, such as, for example, castor oil, castor oil, cottonseed oil, corn oil, olive oil, cod liver oil, almond oil, oil of avocado, palm oil, sesame oil, soybean oil and lanolin. Synthetic oils include, but are not limited to, triolein glyceryl dilaurate and tristearin. Other fatty esters suitable for use in conditioning shampoo compositions
Anti-dandruff P1383 of the present invention are synthetic water-insoluble fatty esters. Some of the preferred synthetic esters conform to the general formula (IX):
wherein R1 is a group of 7 to 9 carbon atoms, alkyl, alkenyl, hydroxyalkyl or hydroxyalkenyl, preferably a saturated alkyl group, more preferably a saturated and linear alkyl group; n is a positive integer that has a value that is from 2 to 4, preferably 3; and Y is an alkyl, alkenyl, hydroxy or substituted carboxy, having about 2 to 20 carbon atoms, preferably about 3 to 14 carbon atoms. Other preferred synthetic esters conform to the general formula (X):
wherein R2 is a group of 8 to 10 carbon atoms, alkyl, alkenyl, hydroxyalkyl or hydroxyalkenyl; preferably a saturated alkyl group, with higher
Pl383 preferably a linear, saturated alkyl group; n and Y are as defined in the previous formula (X). It is believed that preferred synthetic esters provide an improved feeling of wet hair when used in combination with the essential components of the shampoo compositions of the present invention, particularly when used in combination with the cationic polymer component (described below). ). These synthetic esters improve the feeling of damp hair by reducing the viscosity sensation or excessive conditioner of wet hair that has been conditioned by a cationic polymer. Specific non-limiting examples of synthetic fatty esters suitable for use in the anti-dandruff shampoo conditioner compositions of the present invention include: P-43 (Ca-Cio trimethylolpropane triester), MCP-684 (3,3-dietanol-1 tetraester) , 5 pentadiol), MCP 121 (C 8 -C 6 adipic acid diester), all of which are commercially available from Mobil Chemical Company.
3. Other conditioning agents Also suitable for use in the compositions of this invention are the agents
P1383 conditioners described by Procter & Gamble Company in U.S. Patent Nos. 5,674,478, and 5,750,122, which are incorporated herein by reference in their entirety. Also suitable for use in this invention are those conditioning agents described in U.S. Patent Nos. 4,529,586 (Clairol), 4,507,280 (Clairol), 4,663,158 (Clairol), 4,197,865 (L'Oreal), 4,217,914 (L'Oreal). , 4,381,919 (L'Oreal), and 4,422,853 (L'Oreal), all of which descriptions are incorporated herein by reference. Some other preferred silicone conditioning agents for use in the compositions of the present invention include: Abil® S 201 (dimethicone / PG-propyldimethicone sodium thiosulfate copolymer), commercially available from Goldschmidt; DC Q2-8220 (trimethylsilyl amodimethicone) commercially available from Dow Corning; DC 949 (amodimethicone, cetrimonium chloride and Trideceth-12), commercially available from Dow Corning; DC 749 (cyclomethicone and trimethylsiloxysilicate), commercially available from Dow Corning; DC2502 (dimethicone cetyl), commercially available from Dow Corning; BC97 / 004 and BC 99/088 (silicone microemulsions with amino function), commercially available from Basildon Chemicals; GE SME253
P1383 and SM2115-D2 and SM2658 and SF1708 (silicone microemulsions with amino function), commercially available from General Electric; siliconized meadow seed oil, commercially available from Croda; and those silicone conditioning agents described by GAF Corp. in U.S. Patent No. 4,834,767 (quaternized aminolactam), by Biosil Technologies in U.S. Patent No. 5,854,319 (reactive silicone emulsions containing amino acids) and by Dow Corning in U.S. Patent No. 4,898,585 (polysiloxanes), the disclosures of which are incorporated herein by reference.
C. Antidandruff agent The anti-dandruff conditioning shampoo compositions of the present invention comprise between about 0.1% and 4% by weight of the composition, preferably about between 0.1% and 3%, preferably superlative, and about between 0.3% and 2% , of an anti-dandruff agent suitable for application on hair or skin. The anti-dandruff agent provides the shampoo compositions with antimicrobial activity. The antidandruff agent can be particulate or soluble. Non-limiting examples of suitable particulate anti-dandruff agents include: pyridinothione salts,
P1383 selenium sulfide, particulate sulfur and combinations thereof. Preferred are the pyridinothione salts. A non-limiting example of suitable soluble anti-dandruff agents is ketoconazole. This antidandruff agent must be physically and chemically compatible with the essential components of the composition, and must not, on the other hand, unduly deteriorate the stability of the product, its aesthetics or its operation. 1. Pyridinothione salts The anti-dandruff particles of pyridinothione, especially the salts of l-hydroxy-2-pyridinothione, are highly preferred particulate antidandruff agents for use in the anti-dandruff conditioning shampoo compositions of the present invention. The concentration of the anti-dandruff particles of pyridinothione is typically in the range of between about 0.1% and 4% by weight of the composition, preferably between about 0.1% and 3%, preferably superlative of about between 0.3% and 2% . Preferred pyridinothione salts include those formed from heavy metals such as zinc, tin, cadmium, magnesium, aluminum and zirconium, preferably zinc, more preferably the l-hydroxy-2-pyridinothione zinc salt (known as "pyridinothione"). of zinc "or" ZPT "), preferably superlative salts of 1-
P1383 hydroxy-2-pyridinothione with particles in the form of plates, wherein the particles have an average size of up to about 20 μ, preferably up to about 5 μ, preferably superlative up to about 2.5 μ. Salts formed with other cations, such as sodium, may also be suitable. Pyridinothione antidandruff agents are described, for example, in U.S. Patent No. 2,809,971; U.S. Patent No. 3,236,733; U.S. Patent No. 3,753,196; U.S. Patent No. 3,761,418; U.S. Patent No. 4,345,080; U.S. Patent No. 4,323,683; U.S. Patent No. 4,379,753; and U.S. Patent No. 4,470,982, all of which are incorporated herein by reference. It is contemplated that when the ZPT is used as antidandruff particles in the shampoo compositions of this invention, the growth or re-growth of hair may be stimulated or regulated, or both, or that hair loss may be reduced or inhibited, or that the hair may seem thicker or more whole.
2. Selenium sulfide Selenium sulfide is an antidandruff agent in
P1383 particles suitable for use in the antidandruff shampoo conditioner compositions of the present invention, effective concentrations are in the range of between about 0.1% and 4% by weight of the composition, preferably between about 0.3% and 2.5%, more preferably between about 0.5% and 1.5%. Selenium sulfide is generally considered to be a compound that has one mole of selenium and two moles of sulfur, although it can also take the form of a cyclic structure that conforms to the general formula SexSy, where x + y = 8. Average particle diameters for selenium sulfide are typically less than 15 μm as measured by an advanced laser light scattering device (e.g., a Malvern 3600 instrument), preferably less than 10 μm. Selenium sulfide compounds are described, for example, in U.S. Patent No. 2,694,668; U.S. Patent No. 3,152,046; U.S. Patent No. 4,089,945; and U.S. Patent No. 4,885,107, the disclosures of which are incorporated herein by reference.
3. Sulfur Sulfur can also be used as a particulate antidandruff agent in shampoo compositions
P1383 antidandruff conditioner of the present invention. Effective concentrations of sulfur in particles are typically from about 1% to about 4%, by weight of the composition, preferably from about 2% to about 4%.
4. Ketoconazole Ketoconazole can also be used as a soluble antidandruff agent in the antidandruff conditioning shampoo compositions of the present invention. The effective concentrations of ketoconazole are typically from about 0.1% to about 4%, by weight of the composition, preferably from about 0.3% to about 2%.
D. Cationic Polymers The antidandruff conditioning shampoo compositions of the present invention comprise from about 0.02% to 5% by weight of the composition, preferably from about 0.05% to 3%, more preferably from about 0.1% to 2%. %, preferably superlative of approximately between 0.5% and 1%, of at least one organic, cationic deposition and conditioning polymer suitable for application to the hair or skin. It is believed that polymers
P1383 cationics provide an increase in anti-dandruff efficacy and an increase in the conditioner of the shampoo compositions described in this invention. These cationic polymers must be physically and chemically compatible with the essential components described in this invention, and must not, on the other hand, unduly impair the stability of the product, its aesthetics or performance.
1. Characteristics of the cationic polymers The cationic polymers useful in the present invention should be selected and should be present at a level such that the cationic polymers are soluble in the shampoo composition and are preferably soluble in a coacervate complex phase. in the shampoo composition, in dilution. That coacervate is described in detail later. The physical properties of the cationic polymers and suitable counterions are also detailed.
i. Coacervate formed from a cationic polymer A coacervate is formed, in dilution in the shampoo composition, between the cationic polymer and the anionic detersive surfactant component (described above) of the present invention. It is believed that the cationic half of the polymer bonds with the anionic half
P1383 of the surfactant forms an insoluble complex that precipitates, in dilution (the coacervate). The coacervate complexes of the cationic polymer can also be formed with other optional anionic components of the shampoo composition (described below). The formation of the coacervate depends on a variety of criteria, such as molecular weight, component concentration and proportion of ionic components that interact, ionic strength (including the modification of ionic strength, for example, by adding salts), charge density of the cationic and anionic components, pH and temperature. Coacervate systems and the effect of these parameters are described, for example, in J. Caelles, et al., "Anionic and Cationic Compounds in Mixed Systems", Cosmetics & Toiletries, vol. 106, (April 1991), pp. 49-54;
C. J. van Oss, "Coacervation, Complex-Coacervation and
Flocculation ", J. Dispersion Science and Tech., Vol.9 (5.6),
(1988-89), pp 561-73; and in D. J. Burgess, "Practical
Analysis of Complex Coacervate Systems, "J. of Colloid and Interface Science, Vol 140, No. 1, (November 1990), pp 227-38, the descriptions of which are incorporated herein by reference.The shampoo compositions described herein invention, typically have a ratio of anionic detersive surfactant component to cationic polymer component of about 25: 0.02 to
P1383 about 1: 1, preferably from about 20: 0.1 to about 12: 1. It is believed that coacervates provide conditioning benefits, especially benefits of conditioning during the use of the product when the hair is wet, helping to deposit conditioning agents on the hair and scalp. It is known in the technical field that coacervates also aid in the deposition of other types of particulate agents. It is believed that this occurs by concentrating the particles within the limits of the coacervate in dilution. It has also been found that the characteristof the polymer in those compositions can affect the bioavailability / coverage of the antidandruff particles, those characteristinclude the molecular weight of the cationic guar rubber polymer and the charge density. Guar gums with lower molecular weight are preferred, guar gums with lower charge density are preferred. Guar gums with lower molecular weight and lower charge density are highly preferred. It is believed that those selected guar gums impart modified physical properties (e.g. rheology) to the formed coacervates. The techniques for analyzing the formation of coacervate complexes are known in the technical field.
P1383 For example, microscopic analyzes of the shampoo compositions, at any chosen dilution step, can be used to identify whether a coacervate phase has been formed. That coacervate phase can be identified as an additional emulsified phase in the composition. The use of dyes can help distinguish the coacervate phase from other insoluble phases dispersed in the shampoo composition. ii. Physical Properties of the Cationic Polymer The average molecular weight of the cationic conditioning polymers suitable for use in this invention is typically from about 5,000 to 10,000,000, preferably from about 100,000 to 2,000,000, more preferably from about 200,000 to 1,500,000, more preferably about 250,000 to 850,000, more preferably about 350,000 to 500,000. The polymers have a cationic charge density typically of between about 0.1 meq / g and 7 meq / g, measured at the pH of the shampoo composition to be used, preferably about 0.2 meq / g and 5 meq / g, of preferably about 0.5 meq / gm to 2 meq / g, more preferably about 0.6 meq / g to 1 meq / g, more preferably about 0.6 meq / g to 0.9 meq / g.
P138-S The pH of the shampoo composition to be used is typically in the range of from about pH 3 to about pH 9, preferably from about pH 4 to about pH 7.
iii. Counterions used in the formation of a cationic polymer Any anionic counterion can be used in association with the cationic polymers as long as the cationic polymers remain soluble in water, in the shampoo composition, or in a coacervate phase of the shampoo composition, and provided that the counterions are physically and chemically compatible with the essential components of the shampoo composition or that, on the other hand, do not, unduly, impair the performance of the product, its stability or aesthetics. Non-limiting examples of counterions include: halides (eg, chloride, fluoride, bromide, iodide), sulfate, methylisulfate, and combinations thereof.
2. Types of cationic polymers Examples of cationic polymers that might be suitable for use in the shampoo compositions of this invention include, in non-exclusive form, cationic polysaccharides (e.g., cellulose derivatives)
P1383 cationic and cationic guar gums), copolymers of vinyl monomers, copolymers of vinylpyrrolidone, modified cationic proteins and certain quaternary salts of polymers. The cationic polymers are described in detail below. i. Cationic polysaccharides Preferred cationic polymers for use in the anti-dandruff conditioning shampoo compositions of the present invention are those known as cationic polysaccharides. Cationic polysaccharides are those sugar-based polymers having from 5 to 6 carbon atoms and their derivatives that have been made cationic by means of the insertion of cationic moieties into the polysaccharide backbone and include homopolymers, copolymers, terpolymers, etc. , quaternary ammonium or cationic monomer units with substitution of an amine, optionally, in combination with non-cationic monomers. The polysaccharides can be composed of one type of sugar or more than one type of sugar. The cationic amines may be primary, secondary or tertiary amines (preferably secondary or tertiary), depending on the particular species and the selected pH of the shampoo composition. The monomers can be in a straight chain or a branched chain with geometric arrangements. All
P1383 monomer units can have cationic halides containing bound nitrogen, preferably some of the monomer units do not have those halves bound. Non-limiting examples of cationic polysaccharides are described in the CTFA Cosmetic Ingredient Dictionary, 3d ed. , edited by Estrin, Crosley, and Haynes, (The Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, DC (1982), the disclosure of which is incorporated herein by reference.) Polymers of cationic polysaccharides include the following: celluloses and cationic hydroxyethylcelluloses; cationic starches and hydroxyalkyl starches; cationic polymers based on the galactomannan copolymer known as guar gum obtained from the guar bean endosperm; cationic polymers based on arabinose vegetable gums; cationic polymers derived from xylose polymers (such as those found in wood, straw, cottonseed crust, and corn cob); cationic polymers derived from fucose polymers (such as those found as cell wall components in marine algae); cationic polymers derived from fructose polymers
(such as inulin, which is found in certain plants); Cationic polymers based on sugars that contain acids (such as galacturonic acid and acid
P1383 glucouronic); cationic polymers based on sugars and amines (such as galactosamine and glucosamine); cationic polymers based on polyalcohols of 5 and 6 membered rings; cationic polymers based on galactose monomers (such as those found in plant gums and mucilagen); and cationic polymers based on mannose monomers (such as those found in plants, fungi and algae networks). Preferred are celluloses and cationic hydroxyethylcelluloses; cationic starches and hydroxyalkyl starches; cationic polymers based on guar gum and their combinations.
to. Cationic Cellulose Derivatives Cationic polysaccharide polymers suitable for use in the antidandruff shampoo conditioner compositions of the present invention are cationic cellulose derivatives and cationic starch derivatives. Cationic polymers include those that conform to the general formula (XI):
wherein A is a residual group of anhydroglucose (for example a starch or residual cellulose group of
P1383 anhydroglucose); R is an alkynene, oxyalkyloene, polyoxyalkyloene or hydroxyalkyloene group, or a combination thereof; R1, R2, and R3 are independent groups of alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or alkoxyaryl, each group containing up to about 18 carbon atoms and the total number of carbon atoms for each cationic moiety (eg, the sum of carbon atoms in R1, R2, and R3) preferably being about 20 or less; and X is an anionic counterion described above. The cationic cellulose polymers include, in non-exclusive form, those polymers commercially available from Amerchol Corporation, in the JR and LR polymer series, such as the hydroxyethylcellulose salts which reacted with trimethyl ammonium with epoxide substitution, known in the industry ( CTFA) as Polyquaternium 10 (for example JR 30M®, commercially available from Amerchol Corporation). Preferred Polyquaternium polymers 10 for use in this invention typically have a charge density of about 0.3 meq / g to 3 meq / g and a molecular weight of about 200,000 to 1,500,000. Another non-limiting example of a preferred type of cationic cellulose includes the quaternary ammonium salt of hydroxyethylcellulose polymer that is reacted with an epoxide
P1383 of ammonium substituted lauryl dimethyl, known in the industry (CTFA) as Polyquaternium 24, (for example Polymer LM 200®, commercially available from Amerchol Corporation). Also suitable for use in this invention are those copolymers of quaternary nitrogen-containing cellulose, the copolymers of hydroxyethylcellulose which are reacted with diallyldimethylammonium chloride, known in the industry (CTFA) as Polyanartenium 4 (for example Celquat® H-100). , commercially available from National Starch Corporation). The quaternary nitrogen containing cellulose ethers suitable for use in this invention are described in U.S. Patent No. 3,962,418, and still other etherified cellulose and starch copolymers suitable for use in this invention are described in the US Pat. United States No. 3,958, 581, both descriptions are incorporated herein by reference.
b. Cationic guar gum derivatives Other cationic polysaccharide polymers suitable for use in the antidandruff conditioning shampoo compositions of the present invention are the cationic guar gum polymers. Guar gums
Pl383 are substituted by galactomannan gum derivatives (guar). The molecular weight of these derivatives is in the range typically of about 50, 000 to about 2,500,000, preferably from about 50,000 to about 1,000,000, more preferably from about 50,000 to about 700,000, more preferably from about 100,000 to about 350,000. Guar gums to be used in the preparation of guar gum derivatives are typically obtained as a natural material from the seeds of the guar plant. The guar molecule alone is a straight chain with branches of mannan at regular intervals with single-member galactose units on alternating moieties. The mannose units are linked to one another by means of ß (1-4) glycosidic linkages. The galactose branching arises via a bond to (1-6). The cationic derivatives of guar gums are obtained by means of the reaction between the hydroxyl groups of the polygalactomannan and the reactive quaternary ammonium compounds. The degree of substitution of the cationic groups on the structure of the guar gum must be sufficient to provide the required cationic charge density, described above.
P1383 The quaternary ammonium compounds to be used in the formation of the cationic guar gum polymers include those conforming to the general formula (XII):
wherein R1, R2 and R3 are methyl or ethyl groups; R4 is either an epoxyalkyl group with the general formula (XIII):
or R4 is a halohydrin group with the general formula (XIV):
wherein R5 is an alkynene having from 1 to 3 carbon atoms; X is chloride or bromide and Z is an anion such as Cl ", Br", I "or HS04". The polymers of cationic guar gum (cationic guar gum derivatives) formed from the reagents described above are represented by the general formula (XV):
P1383
where R is a guar gum. Preferably, the cationic guar rubber polymer is guar hydroxypropyltrimethylammonium chloride, which can be more specifically represented by the general formula (XVI): cationic guar gum polymers
Specific non-limiting examples of cationic guar gum polymers that conform to formula XVI include: Jaguar® C 13S, which has a cationic charge density of 0.8meq / g (commercially available from Rhodia Company) and Jaguar® C 17, which it has a cationic charge density of 1.6 meq / g (commercially available from Rhodia Company). Other cationic polymers of guar gum include the hydroxypropylated cationic guar gum derivatives. Still other suitable cationic polymers include copolymers of esterified guar gum, some examples which are described in U.S. Patent No. 3,958,581, the disclosure of which is incorporated herein by reference.
P1383 ii. Copolymers of vinyl monomers Other cationic polymers suitable for use in the anti-dandruff conditioning shampoo compositions of the present invention are the copolymers of vinyl monomers, having functionalities of a cationic ammonium or quaternary ammonium, which are reacted with monomers soluble in water. Non-limiting examples of those monomers include: acrylamide, methacrylamide, alkyl and dialkyl acrylamides, alkyl and dialkyl methacrylamides, alkyl acrylate, alkyl methacrylate, vinyl caprolactone, vinyl pyrrolidone and combinations thereof. Preferred substituted alkyl and dialkyl monomers have alkyl groups having from 1 to 7 carbon atoms, more preferably alkyl groups having from 1 to 3 carbon atoms. Other suitable monomers include vinyl esters, vinyl alcohol (made by the hydrolysis of polyvinyl acetate), maleic anhydride, propylene glycol, ethylene glycol and combinations thereof. Suitable protonated and quaternary ammonium cation monomers suitable for inclusion in the cationic polymers of the shampoo composition in this invention include vinyl compounds substituted with dialkylaminoalkyl acrylate, methacrylate
P1383 dialkylaminoalkyl, monoalkylaminoalkyl acrylate, monoalkylaminoalkyl methacrylate, methacryloxyalkyl trialkyl ammonium salt, acryloxyalkyl trialkyl ammonium salt, quaternary ammonium dialkali salts; and quaternary ammonium vinyl monomers having cationic nitrogen containing cyclic rings such as pyridinium, imidazolium and quaternized pyrrolidones, such as for example alkylvinyl imidazolium salts, alkylvinyl pyridinium and alkylvinyl pyrrolidone. The alkyl portions of these monomers are preferably lower alkyls such as alkyls having from 1 to 3 carbon atoms. Amine-substituted vinyl monomers suitable for use in this invention include dialkylaminoalkyl acrylamide and dialkylaminoalkyl methacrylamide, wherein the alkyl groups are preferably hydrocarbyls having 1 to 7 carbon atoms, more preferably alkyls having 1 to 3 carbon atoms.
iii. Vinylpyrrolidone copolymers Other cationic polymers suitable for use in the antidandruff shampoo conditioner compositions of the present invention include: l-vinyl-2-pyrrolidone copolymers and l-vinyl-3-methylimidazole salts
P1383 (for example chloride salts), known in the industry (CTFA) as Polyquaternium 16 (for example Luviquat® FC 370, and obtainable from BASF Wyandotte Corporation); copolymers of l-vinyl-2-pyrrolidone and dimethylaminoethyl methacrylate, known in the industry (CTFA) as Polyquaternium 11 (for example, Gafquat® 755N, and obtainable from ISP Corporation); polymers containing quaternary diallylated cationic ammonium, including, for example, dimethyldiallylammonium chloride homopolymer, known in the industry (CTFA) as Polyquaternium 6; copolymers of acrylamide and dimethyldiallylammonium chloride, known in the industry (CTFA) as Polyquaternium 7; and salts of aminoalkyl mineral acids of unsaturated C3 and C5 homopolymers and copolymers of carboxylic acids, carboxylic acids, such as those described in U.S. Patent No. 4,009,256, the disclosure of which is incorporated herein by reference.
i. Cationic modified proteins and polymeric quaternary salts Still other cationic polymers for use in the antidandruff shampoo conditioner compositions of the present invention are cationic modified proteins, such as for example hydroxypropyl lauryldiammonium collagen
P1383 (for example Croquat® L, and which can be obtained from Croda Corporation), or hydrolyzed hair keratin hydroxypropyl cocoammonium (for example Croquat® HH, available from Croda Corporation). Other cationic polymers include the polymeric quaternary salt prepared by the reaction of adipic acid and dimethylaminopropylamine, which reacts with dichloroethyl ether, known in the industry (CTFA) as Polyquaternium 2
(for example Mirapol® AD-1, and obtainable in Rhodia) and the polymeric quaternary salt prepared by the reaction of azelaic acid and dimethylaminopropyl ether, known in the industry (CTFA) as Polyquaternium 18 (for example Mirapol® AZ-1 and that can be obtained from Rhodia Corporation).
v. Other cationic polymers Still other cationic polymers suitable for use in this invention are the Arquad® series of quaternary ammonium salts, commercially available from Akzo Nobel. Other preferred cationic polymers for use in this invention include: Polymer KG30M
(Polyquaternium 10 and quaternized cellulose), Incroquat® behenyltrimonium methosulfate (cetearyl alcohol and behentrimonium methosulfate), commercially available from Croda; Merquat® 5 (quaternary ammonium resin),
P1383 commercially available at Calgon; Gafquat® series 440 (cationic quaternized copolymers), commercially available from ISP; Akypoquat® 131, commercially available from Kao; Saleare® SC 60 (quaternary ammonium resin), or Saleare® SC95 or SC96 (cationic liquid dispersion thickeners), all commercially available from Ciba; and Meadowquat® HG (PEG-2-dimeadowfoamamidoethylammonium methosulfate), commercially available from Fanning.
E. Water The anti-dandruff shampoo conditioner compositions of the present invention comprise between about 20% and 94.75%, by weight of the composition, preferably between about 50% and 94.75%, more preferably between about 60% and 85%, of water.
II. Optional Components The anti-dandruff shampoo conditioner compositions of the present invention may, in addition, in some embodiments, comprise additional optional components known or otherwise effective for use in hair care or personal care products. Additional surfactants, suspending agents, polyalkylene glycols, regulating agents of the
P1383 hair growth and other optional components that are described in detail below.
A. Other Surfactants The antidandruff shampoo conditioner compositions of the present invention can, in some embodiments, further comprise between about 0.5% and 25% by weight of the composition, preferably between about 1% and 20%, preferably superlative between 1% and 10%, of a surfactant different from the anionic surfactants described above, suitable for application to hair or skin. These other optional surfactants must be chemically and physically compatible with the essential components of the shampoo composition, and should not, on the other hand, unduly impair the performance of the product, its aesthetics or stability. Other suitable surfactants include, in non-exclusive form, zwitterionic, cationic, nonionic amphoteric and combinations thereof. Amphoteric detersive surfactants suitable for use in this invention include, in non-exclusive form, those surfactants widely described as derivatives of secondary and tertiary aliphatic amines in which the aliphatic radical can be a straight or branched chain and wherein one of the substituents
Aliphatic P1383 contains about 8 to 18 carbon atoms and one contains a water-soluble anionic group such as carboxy, sulfonate, sulfate, phosphate or phosphonate. The zwitterionic detersive surfactants suitable for use in this invention include, in non-exclusive form, those surfactants widely described as aliphatic quaternary ammonium derivatives, phosphonium and sulfonium compounds, wherein the aliphatic radicals can be straight or branched chains and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group such as carboxy, sulfonate, sulfate, phosphate or phosphonate. The preferred detersive zwitterionic surfactants are the betaines. Suitable cationic detersive surfactants for use in this invention include, but are not limited to, surfactants containing quaternary nitrogen moieties. Examples of quaternary cationic surfactants are those corresponding to the general formula (XVIII):
P1383
wherein R1, R2 # R3 and R4 are independently selected from an aliphatic group having from 1 to 22 carbon atoms or an aromatic, alkoxy, polyoxyalkyloene, alkylolamido, hydroxyalkyl, aryl or alkylaryl group having up to about 22 carbon atoms, preferably an alkyl of 1 to 22 carbon atoms; and X is a salt-forming anion, such as those selected from a halogen (eg, chloride, bromide) and acetate, citrate, lactate, glycolate, phosphate, nitrate, sulfate and alkyl sulfate radicals. The aliphatic groups may contain, in addition to the carbon and hydrogen atoms, ether linkages and other groups, such as amino groups. The longest chain (for example C12 and greater) of aliphatic groups can be saturated or unsaturated. Preferred cationic detersive surfactants are those containing two long alkyl chains and two short alkyl chains or those containing one long alkyl chain and three short alkyl chains. These long alkyl chains have, preferably, from 12 to 22 carbon atoms, more preferably they have from 16
P1383 up to 22 carbon atoms. The short alkyl chains preferably have from 1 to 3 carbon atoms, more preferably they have from 1 to 2 carbon atoms. Nonionic detersive surfactants suitable for use in this invention include, in non-exclusive form, those compounds produced by condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound, which may be aliphatic or aromatic alkyl in nature. Non-limiting examples of other amphoteric, zwitterionic, cationic and non-ionic detersive surfactants suitable for use in the anti-dandruff shampoo conditioner compositions of the present invention are described in McCutcheon's, Emulsifiers and Detergents, (1989), published by MC Pub. Co. . , and in U.S. Patent No. 2,438,091; U.S. Patent No. 2,528,378; U.S. Patent No. 2,658,072; U.S. Patent No. 3,155,591; U.S. Patent No. 3,929,678; U.S. Patent No. 3,959,461; U.S. Patent No. 4,387,090; U.S. Patent No. 5,104,646; U.S. Patent No. 5,106,609; and U.S. Patent No. 5,837,661, the descriptions of which are
P1383 incorporated herein by reference.
B. Suspension Agents The antidandruff conditioning shampoo compositions of the present invention may, in some embodiments, comprise between about 0.1% and 10% by weight of the composition, preferably between about 0.3% and 5%, more preferably between about 0.3% and 2.5%, of a suitable suspension agent for application on hair or skin. It is believed that the suspending agent suspends the water-insoluble dispersed material found in the shampoo compositions. That suspension agent must be physically and chemically compatible with the essential components of the composition, and should not, on the other hand, unduly deteriorate the stability of the product, its aesthetics or its functionality. Examples of suspending agents which may be suitable for use in shampoo exposures in this invention include, in non-exclusive form, acyl derivatives, long chain amine oxides, xanthan gum and combinations thereof. These and other suitable suspending agents are described in detail below.
1. Acyl derivatives and long-chain amine oxides Acyl-derived suspension agents include, but are not limited to, glyceryl esters, long-chain hydrocarbyls, long-chain esters of long-chain fatty acids, long-chain alkanol esters long chain amides. Another group of suitable suspending agents includes long chain amine oxides. Acyl-derived suspension agents and long-chain amine oxides are described in U.S. Patent No. 4,741,855, the disclosure of which is incorporated herein by reference. Preferred acyl derivative suspending agents for use in this invention are glyceryl esters, which include esters of fatty acids having from 16 to 22 carbon atoms of ethylene glycol. More preferred are tileglycol stearates, both mono- and di-stearates, more preferably ethylene glycol distearate containing about 7% or less of monostearate. Also suitable for use in the shampoo compositions in this invention are the long chain hydrocarbyls (for example Cs-C2), which include N, N-dihydrocarbylamidobenzoic acid and its soluble salts (e.g., Na, K) and species of this family of
P1383 amidobenzoic acid, commercially available from Stepan Company. Non-limiting examples of long chain esters of long chain fatty acids include: stearyl stearate and cetyl palmitate. Non-limiting examples of long-chain esters of long chain alkanol amides include: stearamide diethanolamide distearate and stearamide monoethanolamide stearate. Non-limiting examples of suitable long-chain amine oxides to be used as suspending agents in this invention include the amino-dimethyl-e-C22-alkyl oxides (for example, amino-dimethyl-stearyl oxide).
2. Xanthan gum Also suitable as a suspending agent in this invention is xanthan gum. The concentration of xanthan gum is typically in the range of about 0.1% to about 3%, by weight of the composition, preferably from about 0.4% to about 1.2%. The use of xanthan gum as a suspending agent in shampoo compositions containing silicone is described, for example, in the patent of the
United States No. 4,788,006, the disclosure of which is incorporated herein by reference. Combinations of long chain acyl derivatives and xanthan gum can also be used as a suspending agent in shampoo compositions, as described in U.S. Patent No. whose description is incorporated herein by reference.
3. Other suspending agents Still other suspending agents suitable for use in the anti-dandruff conditioning shampoo compositions of the present invention include carboxyvinyl polymers. Preferred among these polymers are copolymers of acrylic acid crosslinked with polyallyl sucrose, as described in U.S. Patent No. 2,798,053, the disclosure of which is incorporated herein by reference. Examples of these polymers include Carbopol 934,940,941, and 956, commercially available from B. F. Goodrich Company. Another suitable suspending agent for use in this invention includes primary amines with fatty alkyl moieties having at least about 16 carbon atoms (e.g. palmitamine, and steramine) and secondary amines having two fatty alkyl moieties each having at least about 12 carbon atoms (for example dipalmitoylamine, and di- (hydrogenated tallow) -amine). Also suitable are phthalic acid amides di- (tallow)
P1383 hydrogenated) and the vinyl ether copolymer crosslinked with maleic anhydride. Yet another suitable suspending agent can be used in shampoo compositions, including those that can impart a gel-like viscosity to the composition, such as water soluble or colloidal water soluble polymers such as cellulose ethers (eg, methylcellulose, hydroxybutyl methylcellulose, hydroxypropylcellulose, hydroxypropyl methylcellulose, hydroxyethyl ethylcellulose and hydroxyethylcellulose) , guar gum, polyvinyl alcohol, polyvinyl pyrrolidone, hydroxypropyl guar gum, starch and starch derivatives and other thickeners, viscosity modifiers, gelling agents and their combinations. A preferred viscosity modifier useful as a suspending agent is trihydroxystearin (for example Thixin R ™, commercially available from Rheox Company).
C. Polyalkylene Glycol The antidandruff conditioning shampoo compositions of the present invention may, in some embodiments, further comprise between about 0.005% and 1.5% by weight of the composition, preferably between about 0.05% and 1%, more preferably between 0.1 % and 0.5%, with superlative preference between
P1383 approximately 0.1% and 0.3%, polyalkylene glycol selected suitable for application on hair or skin. It is believed that the selected polyalkylene glycols provide an improved foam function, that they improve the shampooing ability of the shampoo and when an antidandruff agent is used, it increases the antidandruff efficacy, to the compositions described in this invention. These polyalkylene glycols must be physically and chemically compatible with the essential components described in this invention and should not, on the other hand, unduly deteriorate the stability of the product, its aesthetics or its functionality. It has been found that those polyalkylene glycols, when added to the shampoo compositions described in this invention, increase the function of formation of esp-uma leaving a richer and denser foam that correlates the consumer's perception of a conditioning function of the hair. It has also been found that, in those embodiments containing silicone conditioning agents, the selected polyalkylene glycols can reduce the concentration of the anionic detersive surfactant necessary to provide a hair cleaning. In those reduced surfactant compositions, hair cleaning and conditioner function remain good, while improving
P1383 the global function of foam formation. It is known that polyethylene glycols, for example, are used to improve the foaming function in cleaning compositions, as described in U.S. Patent No. 5,837,661, the disclosure of which is incorporated herein by reference. It has also been found that these selected polyalkylene glycols, when added to a silicone-containing shampoo composition, improve the spreadability of the shampoo compositions on the hair. The improved smearing ability of the shampoo composition during application also provides the perception in consumers of an improved conditioning function. This function is especially surprising in the selected polyalkylene glycol known to be a thickening agent and as a thickening agent it would be expected that it would deteriorate rather than improve the ability of the shampoo compositions on the hair to be smeared. The polyalkylene glycol suitable for use in the shampoo compositions in this invention are characterized by having the general formula (XVII):
P1-S83 HCOC ^ CDn-OH R
wherein R is hydrogen, methyl or combinations thereof, preferably hydrogen, and n is an integer having an average value of between about 1,500 and 120,000, preferably between about 1,500 and 50,000, more preferably between about 2,500 and 25,000 , and with superlative preference of between approximately 3,500 and 15,000. When R is hydrogen, these materials are polymers of ethylene oxide, which are also known as polyethylene glycol. When R is methyl, these materials are polymers of propylene oxide, which are also known as polypropylene glycol. When R is methyl, it is also understood that several positional isomers of the resulting polymers may exist. Preferred for use in this invention are polyethylene glycol, polypropylene glycol and combinations thereof. Specific non-limiting examples of polyethylene glycol polymers to be used in the anti-dandruff conditioning shampoo compositions of the present invention include: PEG 2M, wherein R is hydrogen and n has an average value of about 2,000 (for example Poliox WSR® N-10, commercially available in Union Carbide); PEG
P1383 5M, wherein R is hydrogen and n has an average value of about 5,000 (for example Poliox WSR® N-35 and Poliox WSR® N-80, both commercially available from Union Carbide); PEG 7M, wherein R is hydrogen and n has an average value of about 7,000 (for example Poliox WSR® N-750, commercially available from Union Carbide); PEG 9M, wherein R is hydrogen and n has an average value of about 9,000 (for example Poliox WSR® N-3333, commercially available from Union Carbide); PEG 14 M, wherein R is hydrogen and n has an average value of about 14,000 (for example Poliox WSR® N-3000, commercially available from Union Carbide); PEG 23M, wherein R is hydrogen and n has an average value of about 23,000 (for example Poliox WSR® N-12k, commercially available from Union Carbide); PEG 90M, wherein R is hydrogen and n has an average value of about 90,000 (for example Poliox WSR® 301, commercially available from Union Carbide); and PEG 100M, wherein R is hydrogen and n has an average value of about 100,000 (for example Carbowax PEG 4600 ™, commercially available from Union Carbide). Preferred polyethylene glycol includes PEG 7M, PEG 14M, PEG 25M, PEG 90M, and combinations thereof.
D. Hair growth regulating agents
P1383 The compositions in this invention can optionally also comprise, in addition to zinc pyrithione, another hair growth regulating agent. That agent can be chosen from a wide variety of molecules that can function in different ways to improve the hair growth effects in a compound of the present invention. These optional agents, when present, are typically used in the compositions of this invention at a level of between about 0.001% and 15%, preferably of about 0.10 and 10%, preferably superlative of between about 0.5% and 5% by weight of the composition. As used in this invention, the term "hair growth regulator" includes: stimulating hair growth and / or hair thickening; prevention, reduction and / or retardation of hair loss and / or thinning of the hair-increase in the speed of hair growth; induction of the formation of a greater number of hair streaks; increase in the diameter of the stretch marks of hair; growth of hair streaks; hair follicle change from hair to terminal; conversion of follicles from telogen phase to anagen phase (thus increasing the overall proportion of phase follicles
P1383 anagena in relation to the follicles of the telogen phase); alopecia treatment; and any combination. Vasodilators such as potassium channel antagonists including, for example, minoxidil and derivatives of such as aminaxyl and such as those described in U.S. Patent No. 3,382,247, U.S. Patent No. 5,756,092, issued on 26 May 1998, U.S. Patent No. 5,772,990, issued June 30, 1998, U.S. Patent No. 5,760,043, issued June 2, 1998, U.S. Patent No. 328,914, granted on July 12, 1994, U.S. Patent No. 5,466,694, issued November 14, 1995, 5,438,058, issued August 1, 1995, and U.S. Patent No. 4,973,474, issued on June 27, 1995; November 1990, (all of which are incorporated herein by reference), and chromacalin and diazoxide can be used as optional hair growth regulating agents in the compositions herein. An optional class of optional enhancers of the activity to be used are antiandrogens. Examples of suitable antiandrogens may include, unrestrictedly, 5-a-reductase inhibitors, such as, for example, finasteride and those described in the US Pat.
P1383 United States No. 5,516,779, issued May 14, 1996 (which is incorporated herein by reference) and in Nnane et al., "Cancer Research 58," Effects f Some Novel Inhibitors of C17.20-Lyase and 5a-Reductase in Vitro and in Vivo and their Potential Role in the Treatment of Prostate Cancer, as well as cyproterone acetate, azelaic acid and its derivatives and the compounds described in U.S. Patent No. 5,480,913, issued January 2, 1996, flutamide, and those described in United States patents 5,411,981 issued May 2, 1995 and 5,565,467 issued October 15, 1996 and United States Patent 4,910,226 issued March 20, 1990, all incorporated to the present, as a reference. Another suitable class of hair growth regulating agent are immunosuppressants such as: 1) cyclosporin and cyclosporin analogues including those described in U.S. Provisional Patent Application No. 60 / 122,925, Fulmer et al., "Method of Treating Hair Loss Using Non-Immunosuppressi and Compounds ", published March 5, 1999, incorporated herein by reference and 2) F 506 analogs such as those described in U.S. Provisional Patent Application No. 60 / 102,449, Mclver et al., "Heterocyclic 2-Substituted
P1383 Ketoamides ", published on September 30, 1998, U.S. Provisional Patent Application No. 60 / 102,448, Mclver et al.," 2-Substituted Ketoqmides ", filed September 30, 1998, patent application Provisional No.60 / 102, 539, Mclver et al., "2-Substituted Heterocyclic Sulfonamides", filed September 30, 1998, United States Provisional Patent Application No.60 / 102, 458 Tiesman et al., "Method of Treating Hair Loss Using Ketoamides", filed September 30, 1998 and United States Provisional Patent Application No. 60 / 102,437, Mclver et al., "Method of Treating Hair Loss Using Sulfonamides", filed on September 30, 1998, all of which are incorporated herein by reference.
Another suitable class of optional hair growth regulating agent are antimicrobials such as selenium sulfide, ketoconazole, triclocarbon, triclosan, zinc pyrithione, itraconazole, Asian acid, hinoquiithiol, mipirocin and those described in EPA 0,680,745 (incorporated herein) as a reference), clinazine hydrochloride, benzoyl peroxide, benzyl peroxide and minocycline. Other anti-inflammatories may also be incorporated into the compositions in this invention as
P1383 optional activity intensifiers. Examples of suitable anti-inflammatories may include glucocorticoids such as hydrocortisone, mometasone furoate and prednisolone, non-steroidal antiinflammatories including cyclooxygenase or lipoxygenase inhibitors such as those described in U.S. Patent No. 5,756,092, and benzydamine, salicylic acid and those compounds described in EPA 0,770,399, published May 2, 1997, WO 94/06434, published March 31, 1994 and FR 2,268,523 published November 21, 1975, all of which are incorporated herein by reference. Another suitable class of optional hair growth regulating agent are thyroid hormones and their analogous derivatives. Examples of suitable thyroid hormones for use in this invention may include triiodothyronine. Examples of thyroid hormone analogues which may be suitable for use herein include those described in U.S. Provisional Patent Application No. 60 / 136,996, Zhang et al., "Method of Treating Hair Loss", filed on June 1, 1999, U.S. Provisional Patent Application No. 60,137,024, Zhang et al., "Method of Treating Hair Loss Using Biphenyl Compounds", filed on June 1, 1999, the provisional patent application ofP1383 United States No. 60 / 137,022, Zhang et al., "Method of Treating Hair Loss Using Carboxyl Derivatives", filed June 1, 1999, provisional application of United States Patent No. 60 / 137,023, Zhang et al. al., "Method of Treating Hair Loss Using Sulfonyl Thyromimetic Compounds," filed June 1, 1999, U.S. Provisional Patent Application No. 60 / 137,052, Youngquist et al., "Biaryl Compounds," filed on 1 June 1999, U.S. Provisional Patent Application No. 60 / 137,063, Youngquist et al., "Sulfur-Bridged Compounds", filed June 1, 1999 and U.S. Provisional Patent Application No. 60 / 136,958, Youngquist et al., "Substituted Biaryl Ether Compounds", filed June 1, 1999. Prostaglandin agonists can also be used as optional hair growth regulating agents in the compositions herein. Examples of prostaglandin agonists or antagonists include latanoprosta and those described in WO 98/33497, Johnstone, published August 6, 1998, WO 95/11003, Stjernschantz, published April 27, 1995, JP 97- 100091, and Ueno, JP 96-134242, Nakamura. Another class of hair growth regulating agents, optional to be used in this
P1383 invention, are the retinoids. Suitable retinoids may include isotretinoin, acitretin, tazarotene. Non-limiting examples of penetration enhancers that can be used as optional hair growth regulating agents in this invention include, for example, 2-methylpropan-2-ol, propan-2-ol, ethyl-2-hydroxypropanoate, hexan -2, 5-diol, POE (2) ethyl ether, di (2-hydroxypropyl) ether, pentan-2,4-diol, acetone, POE (2) methyl ether, 2-hydroxypropionic acid, 2-hydroxyoctanoic acid, propan-1 -ol, l, 4-dioxane, tetrahydrofuran, butan-1,4-diol, propylene glycol diperlargonate, polyoxypropylene 15 stearyl ether, octyl alcohol, oleyl alcohol ester POE, oleyl alcohol, lauryl alcohol, dioctyl adipate, dicapryl adipate, adipate di-isopropyl, di-isopropyl sebacate, dibutyl sebacate, diethyl sebacate, dimethyl sebacate, dioctyl sebacate, dibutyl suberate, dioctyl azelate, dibenzyl sebacate, dibutyl phthalate, dibutyl azelate, ethyl myristate, dimethyl azelate, butyl myristate, succ dibutyl inate, didecyl phthalate, decyl oleate, ethyl caproate, ethyl salicylate, isopropyl palmitate, ethyl laurate-, 2-ethylhexyl pelargonate, isopropyl isostearate, butyl laurate, benzyl benzoate, benzoate of butyl, laurate
P1383 hexyl, ethyl caprate, ethyl caprylate, butyl stearate, benzyl salicylate, 2-hydroxypropanoic acid, 2-hiroxyoctanoic acid, methylsulfoxide, N, N-dimethylacetamide, N, N-dimethylformamide, 2-pyrrolidone, 1-methyl -2- pyrrolidone, 5-methyl-2-pyrrolidone, 1,5-dimethyl-2-pyrrolidone, l-ethyl-2-pyrrolidone, phosphine oxides, sugar esters, tetrahydrofurfural alcohol, urea, diethyl-m-toluamide , l-dodecylazacylheptan-2-one and those described in U.S. Patent No. 5,015,470, issued May 14, 1991 and U.S. Patent No. 5,496,827, issued July 15, 1994 (which they are incorporated herein by reference in their entirety). Another class of hair growth regulating agent to be used in this invention includes flavinoids, ascomycin derivatives and their analogues, histamine antagonists such as diphenhydramine hydrochloride, other triterpenes such as oleanolic acid and ursolic acid, and those described in U.S. Patent No. 5,529,769, JP 10017431, WO 95/35103, U.S. Patent No. 5,468,888, JP 09067253, WO 92/09262, JP 62093215, U.S. Patent No. 5,631,282, U.S. Pat. of the United States No. 5,679,705, JP 08193094, saponins such as those described in EP 0,558,509 to Bonte et al.
P1383 al, published September 8, 1993 and WO 97/01346 to Bonte et al, published January 16, 1997 (which are incorporated herein by reference in their entirety), proeoglycanase or glycosaminoglycanase inhibitors such as those disclosed in U.S. Patent No. 5,015,470, issued May 14, 1991, U.S. Patent No. 5,300,284, issued April 5, 1994, and U.S. Patent No. 5,185,325. , issued February 9, 1993 (which are incorporated herein by reference in their entirety), estrogen agonists and antagonists, pseudoterines, cytokines and growth factor promoters, analogs or inhibitors such as interleukin-1 inhibitors, Interleukin-6 inhibitors, interleukin-10 promoters and tumor necrosis factor inhibitors, vitamins such as vitamin D analogs and parathyroid hormone antagonists, an biologics of vitamin B12 and panthenol, interferon agonists and antagonists, hydroxy acids such as those described in U.S. Patent No. 5,550,158, anticonvulsants of benzophenones and hydantoin such as phenytoin. Other hair growth agents are described in detail in, for example, JP 09-157,139 to Tsuji et al published on June 17, 1997; EP 0277455 Al a
P1383 Mirabeau, published on August 10, 1988; WO 97/05887 to Cabo Soler et al, published on February 20, 1997; WO 92/16186 to Bonte et al, published March 13, 1992; JP 62-93215 to Okazaki et al, published on April 28, 1987; U.S. Patent No. 4,987,150 to Kurono et al issued January 22, 1991; JP 290811 to Ohba et al, published October 15, 1992; JP 05-286,835 to Tanaka et al, published on November 2, 1993, FR 2,723,313 to Greff, published on August 2, 1994, United States Patent No. 5,015,470 to Gibson issued May 14, 1991, U.S. Patent No. 5,559,092, issued September 24, 1996, U.S. Patent No. 5,536,751 issued July 16, 1996, U.S. Patent No. 5,714,515, issued February 3, 1998 , EPA 0,319,991 published June 14, 1989, EPA 0,357,630 published October 6, 1988, EPA 0,573,253 published December 8, 1993, JP 61-260010 published November 18, 1986, United States Patent No 5,772,990 issued June 30, 1998, United States Patent No. 5,053,410 issued October 1, 1991 and United States Patent No. 4,761,401 issued August 2, 1988, all of which are incorporated in this invention by reference. Some regulatory agents of growth of
Preferred hair for use in this invention are zinc salts of carboxylic acids, saponins, triterpenes, oleanolic acid, ursolic acid, betulinic acid, crataegolic acid, celastrol, Asian acid, 5-a-reductase inhibitors, progesterone, 1,4 -methyl-4-azasteriods, 17-ß-N, N-diethylcarbonyl-4-methyl-aza-5-a-yrostan-3-one, pyrogen receptor antagonists, cyproterone acetate, minoxidil, azaléic acid and derivatives, cyclosporine, triiodothyronine, diazoxide, potassium channel openers, cromakaline, phenytoin, ketoconazole, finiesteride, dutasteride, coal tar, zinc gluconate, glucocorticoids, macrolides, aminaxyl and combinations thereof.
E. Other Optional Ingredients The antidandruff shampoo conditioner compositions of the present invention may, in some embodiments, further comprise additional optional components known or otherwise effective for use in hair care or personal care products. The concentration of those optional ingredients is generally in the range from zero to about 25%, more typically between about 0.05% and 25%, even more typically from about 0.1% to 15% by weight of the composition.
P1383 These optional components must also be physically and chemically compatible with the essential components described in this invention, and must not, on the other hand, unduly deteriorate the stability of the product, its aesthetics or its operation. Non-limiting examples of optional components to be used in the shampoo composition include antistatic agents, foam propellants, anti-dandruff agents in addition to the anti-dandruff agents described above, viscosity adjusting agents and thickeners, pH adjusting agents (eg, sodium citrate) , citric acid, succinic acid, phosphoric acid, sodium hydroxide and sodium carbonate), preservatives (for example DMDM hydantoin), antimicrobial agents (for example triclosan or triclocarbon), dyes, organic solvents or diluents, nacreous aids, perfumes, fatty alcohols, proteins, active skin agents, sunscreen, vitamins and pediculocids. Optional antistatic agents such as water insoluble cationic surfactants can be used, typically in concentrations that are between about 0.1% and 5% by weight of the composition. These antistatic agents should not, on the other hand, interfere with the use and operation and final benefits of the
P1383 shampoo composition; in particular, antistatic agents should not interfere with the anionic surfactant. A specific non-limiting example of suitable antistatic agents is tricetylmethylammonium chloride. Optional foam propellants for use in the shampoo compositions described in this invention include fatty esters (for example C8-C22) mono- and di (C1-C5, especially C1-C3) alkanolamides. Specific non-limiting examples of the foam propellants include coconut monoethanolamide, coconut diethanolamide and combinations thereof. Optional viscosity modifiers and thickeners may be used typically in effective amounts for the antidandruff conditioning shampoo compositions of the present invention to generally have an overall viscosity of between about 1,000 and 20,000 centistokes, preferably about 3,000 to 10,000 centistokes. Specific non-limiting examples of those viscosity modifiers and thickeners include: sodium chloride, sodium sulfate and combinations thereof.
III. Methods of Processing The antidandruff conditioning shampoo compositions of the present invention can be prepared
P1383 by any known or otherwise effective technique, suitable for providing a shampoo composition as long as the resulting composition provides the excellent feeling of hair benefits described in this invention. The methods for preparing the antidandruff conditioning shampoos of the present invention include conventional formulations and blending techniques. A method such as that described in U.S. Patent No. 5,837,661, the disclosure of which is incorporated herein by reference, may be used, wherein the anti-dandruff agent of the present invention would typically be added in the same step as the silicone premix is added in the description of 661.
IV. Methods of Use The anti-dandruff shampoo conditioner compositions of the present invention are used in a conventional manner for cleansing and conditioning the hair or skin are, in particular, used in a conventional manner to treat the condition commonly known as dandruff. An effective amount of composition for cleansing and conditioning the hair or skin is applied to the hair, or to another region of the body, which has preferably been moistened, generally with water, and
P1383 subsequently the composition is rinsed. Effective amounts are typically in the range of about 1 g to about 50 g, preferably from about 1 g to about 20 g. Application to hair typically involves a job of penetrating the composition through the hair in such a way that most, or all the hair is in contact with the composition. This method of providing anti-dandruff efficacy and conditioning of the hair comprises the steps of: (a) wetting the hair with water, (b) applying an effective amount of the shampoo composition to the hair, and (c) rinsing the shampoo composition of the hair. Hair using water. These steps can be repeated as many times as desired to achieve the cleaning, conditioning and anti-dandruff benefits sought. It is also contemplated that when the anti-dandruff particle used is zinc pyrithione and / or another optional hair growth regulating agent if it is used, the shampoo compositions of the present invention can provide a regulation of hair growth. The method of using these shampoo compositions on a regular basis comprises steps a, b and c (above).
P1383 ANALYTICAL METHODS The anti-dandruff shampoo conditioner compositions of the present invention, when applied to hair in a manner consistent with the methods of use described below, provide a superior combination of anti-dandruff efficacy and conditioning. Shampoo compositions, when applied to the hair exhibit certain physical characteristics, which are measured by means of the bioavailability / coverage index, the first conditioning index (wet detangle), the second conditioning index (clean hair feeling) and the index of minimum inhibitory concentration. The methods used to determine the values of these indices are described in detail below.
A. Methods for evaluating the bioavailability / coverage index The bioavailability / coverage index of a shampoo composition is indicative of the anti-dandruff efficacy provided by the shampoo. Generally, the greater the value of the composition index, the better its anti-dandruff efficacy, due to the increased bioavailability of the anti-dandruff agent, the increased coverage of the anti-dandruff agent, or both.
P1383 1. Principle Product, control and placebo samples are applied to portions of pork skin, which are soaped and rinsed. Contact agar boxes inoculated with Malassezia fúrfur are exposed to the surface of the pig skin and after an incubation period, the boxes are analyzed using commercially available software to determine the area of the agar surface in which there has been growth of colonies of M. fúrfur. Indices are calculated by comparing the colonized area in a relative control with the colonized area in each sample. The inhibition of the growth of M. fúrfur on the boxes is indicative of the bioavailability of the anti-dandruff agent and of the coverage of the antidandruff agent, which, together and independently, are indicative of the global antidandruff efficacy.
2. Equipment
Pig skin sterilized via irradiation; shaved, full thickness, size = dependent on the number of products examined
P1383 (typically at least 2100 cm2 approximately) Product 1.5 ml per product to be examined Control 1.5 ml per control to be examined Placebo 1.5 ml per placebo to be examined Beaker 3000 ml Petri dishes 1 per sample to be examined; size = 15 mm x 150 mm; sterilized 4 agar boxes per sample to be examined; size = 35mm x 10mm contact Microrganism 10 μl of M. fúrfur (ATCC 14521) in culture broth per sample to be examined Variable volumetric pipettes 10 μl-100 μl ImagePro Plus® data system training software
P1383 imaging, available from Fryer Company (Hundey, Illinois), or equivalent Microsoft Excel® statistical software software, available from Microsoft Corporation, or equivalent; executed in two rows, hornoscedastico, test T.
3. Reagents A. Broth formulation (adjusted to pH 5.6 with 5N HCl)
Component Quantity Oxigall1 15.0 g / l Polypeptone2 5.0 g / l Peptone Gelisato3 5.0 g / l Palmitic acid 1.0 ml / l Miristic Acid 1.0 ml / l Sodium lactate 10.0 ml / l
P1383 (agar) 15.0 g / l
1. Fresh dehydrated bile, commercially available in Difco Co pany. 2. Pancreatic casein digestion and peptic digestion of animal tissue, commercially available from the BBL Company.
3. Pancreatic gelatin digestion, commercially available from the BBL Company.
B. Control and placebo formulations (% by weight, of the composition)
Component Control Placebo Sulfate 15.00 15.00 ammoniumlaureth-3 Sulfate laurel 5.00 5.00 ammonium Sodium Lauroil 1.50 1.50 Sarcosinate1 Distearate 1.50 1.50 ethylene glycol Polyquaternium 102 0.025 0.025 Polyethylene glycol3 0.125 0.125 Pyridinetiona 1.00 zinc4
P1383 Sodium sulphate 0. 875 0. 875 DMDM hydantoin 0. 2035 0. 2035 Lauryl alcohol 0. 15 0. 15 Perfume 0. 65 0. 65 Water5 amount sufficient i-nn Ht-e- 1. Hamposil L-30, as an active 30% solution, commercially available from Hampshire Chemical Company. 2. UCARE Polymer JR 30M, available in Amerchol. 3. Carbowax 600 (known as PEG 12), commercially available from the Sentry Company. 4. ZPT with an average particle size of approximately 2.5 μm, commercially available from Arch / Olin. 5. After the control and placebo are prepared, adjust the pH of the control and placebo to within the range of about pH 5 to about pH 7, using conventional pH modifiers.
4. Experimental procedure A. Preparation of the contact boxes 1) Add 7.5 ml of molten agar to a Petri dish lid and allow the agar to solidify. 2) Store the box from approximately 12 hours to approximately 24 hours at 30 ° C.
P1383 B. Preparation of pig skin 1) Store pig skin at 0 ° C until needed.
2) Thaw the pork skin at room temperature for 3 hours and dry it with paper towels. 3) Cut the pork skin into pieces of 10 cm x 10 cm; 3 pieces for each product, control and placebo to be examined. 4) Place the pieces of pork skin in Petri dishes separately until they are ready to wash.
C. Test Setup 1) Wash each piece of pig skin by applying 0.5 ml of sample to the surface of the pig skin and soaping for 1 minute over the entire surface. 2) Gently rinse the surface of the pig skin by immersing it in a beaker for 5 seconds. 3) Perform steps 1 and 2 on two additional pieces of pig skin for a total of 3 per sample to be examined. 4) Allow the surface of the skin to dry with air in a sterile petri dish (with the lid cracked) for about 2 hours. 5) Inoculate the contact boxes with 10 μl of M. fúrfur (suspended in a broth at a concentration of
P1383 1.3 x 105 cfu / ml). 6) Press each box of contact agar (4 per piece of pig skin, a total of 12 per product, control and placebo to be examined) firmly against the surface of treated pig skin for 15 minutes. Remove the contact boxes and incubate them for approximately 72 hours at approximately 168 hours at 30 ° C. i) At periodic times during the incubation, analyze the control contact boxes and the placebo contact boxes using the imaging software to determine the area of the contact surface of the boxes in which there has been growth of colonies of M. fúrfur. ii) Compare the average colonized area of the control contact boxes against the colonized average area of the placebo contact boxes and calculate the proportion by dividing the colonized average area of the control contact boxes by the average colonized area of the boxes of placebo contact. iii) When the ratio is between approximately 0.40 to approximately 0.60, finish the incubation.
D. Analysis of antimicrobial activity
P1383 1) After incubation, analyze the contact boxes of the product using the imaging software to determine the average surface area of the contact boxes in which growth of M. fúrfur colonies occurred. 2) Apply a statistical standard T test to determine if the products tested are significantly different from the P value less than or equal to 0.10. These tested products can be significantly different at this level. 5. Determination of the value of the index Compare the average colonized area of the control contact boxes against the colonized average area of the product contact boxes and calculate a proportion by dividing the colonized average area of the control contact boxes by the average of the colonized area of the contact boxes of the product. For example, if the average colonized area of the control contact boxes is 400 mm2 and the colonized average area of the contact boxes of the product is 500 mm2, then the index is 400 mm2 / 500 mm2, which is equal to one value of the index of 0.80.
B. Method to evaluate the index of the first conditioning
P1383 * 8 The value of the first conditioning index is related to the conditioning, as understood by the consumers of the shampoo composition.
Generally, the lower the value of the index of the composition, the better is its conditioning, due to a better wet hairstyle and a less tangled wet hair.
1. Principle Product samples are ied to a horsetail of false hair, which is then soaped and rinsed. The conditioning is graded by the force required to pull a comb through the hair. That force is measured using a force transducer or a load cell. The hair is fixed to be hung vertically in the force transducer. When a force, when combed, is ied to the force transducer, the force units are represented by a voltage that is proportional to the ied force. The voltage signal of the load cell is transferred to a computer through a commercially available digital analog interface. The voltage signal is converted into a numerical value by commercially available computer software. Each time the force is ied to the force transducer, a
P1383 force / time curve. Within the run of a single sample of multiple ied forces, the generated value is the sum of the integration of these force / time curves. That value is called combing force. Because the device is not calibrated to the computer, all multiple sample tests are evaluated by a relative comparison. The conditioning of a sample is reported as an index against a control.
2. Equipment
Straight hair Dark brown, European hair, virgin combination; weight = 4 grams of hair to be worked; length = 8 inches; commercially available in International Hair Importers and Products; 15 hair changes by product to examine (6 for products and 9 for controls) Sink Conventional laboratory sink with a horizontal bar placed
P1383 ^ oximately 20 inches above it Water temperature = 100 ° F, fed through a flexible hose Combs 1 for tested hair; barber plastic comb, oximately 9 teeth / inch Stopwatch That can measure seconds
Product 3cc product / change Computer Capable of running software Rash-8, or equivalent Load cell force transducer of lOOOg, Model # FTD-G-1000, commercially available from Schaevitz Company, or equivalent Dash-8® analog / digital interface commercially available in Metrabyte Company, or equivalent Dash-8® Software, commercially available from Metrabyte Company, or equivalent
P1383 3. Reagents A. Control composition
Raw material (weight%) Ammonium laureth sulfate-3 15.00
Ammonium lauryl sulfate 5.00
Sodium Lauroil Sarcosinate1 1.50 Ethylene glycol distearate 1.50 Poliquat 10 '0.025
Zinc pyridinethione3 1.00 Polyethylene glycol4 0.125 Sodium sulfate 0.875 DMDM Hidantoin 0.2035 Lauryl alcohol 0.15 Water5 cbp 1. Hamposyl L-30, as a 30% active solution, commercially available from Hampshire Chemical Company.
2. UCARE Polymer JR 30M, commercially available in Amerchol. 3. ZPT with an average particle size of oximately 2.5 μm, commercially available in
Pl383 Arch / Olin. 4. Carbowax 600 (known as PEG 12), commercially available from Sentry Company. 5. Adjust the pH from about pH 5 to about pH 7, using conventional pH modifiers.
B. Composition of initial hierarchical hair classification
Raw material weight% Laureth-3 ammonium sulfate 51.24 Lauryl ammonium sulfate 36.38 Cocamide DEA 2.30 Ammonium xylene sulphonate 3.50 Perfume 0.50 Water sufficient amount
4. Experimental procedure A. Initial hierarchical hairstyle classification 1) All false hair must be cleaned and classified hierarchically before conducting each test to determine the index of the first conditioning in order to adjust the function of the uncontrollable variables between each non-permanent hair. treated within a given set. This procedure of
P1383 classification groups specific hair in subsets or groups, in such a way that the function of all the groups together is uniform. 2) Collect all the hair that will be used in the test. 3) Treat the pile hair according to the protocol detailed in Part B below, using the initial composition of hair classification instead of the test products, however, use the composition of the control where designated. 4) Select the hair that has combing forces within the same range of the lower force (typically 2 standard deviations of the lower). 5) Fix the hair in groups in such a way that the combing force of the baseline is evenly distributed across all the treatment groups. For example, if 12 changes are going to be used in 3 test groups, then classify them according to: the hair with the highest hairstyle is placed in Group 1, the hair with the second highest in Group 2, the hair with the third highest in Group 3, the hair with the fourth highest in Group 1, etc.
P1383 B. Hairline Treatment 1) Hang a hairline above the sink on a horizontal bar and wet it completely using water at 100 ° F and at a flow rate of 1.5 gallons / minute. 2) Squeeze the excess water. 3) Apply 0.4 cc of a test or control sample uniformly under the false hair, using at least 8 false hair per product examined. Apply the samples to the artificial hair in a round-robin fashion, for example to the hair # 1 of each set-sample # 1, then to the hair # 1 of each set, sample # 2, etc. An example is to apply in the following order: ÍA, IB, 1C, 2A, 2B, 2C, 3A, 3B, 3C, etc., where the letters refer to a product to be tested and the numbers refer to a replicative number. 4) Using the thumb and the index finger, extract a sample to the change of false hair for 30 seconds. 5) Rinse the hair with water at 100 ° F for 30 seconds. Support the back of the hair, while waiting for the water to wet the hair completely. 6) Squeeze the excess water.
P1383 7) Apply 0.4 cc of test sample or control uniformly down the hair, again in a circular (round-robin). 8) Work the product on the hair while detaching the hair, using a side-to-side movement, for 30 seconds. 9) Rinse with water at 100 ° F for 60 seconds. 10) Squeeze the excess water. 11) After all treatments are completed, untangle the hair while it is still wet, using a comb, as described below (Part C).
C. Unraveling and data collection 1) Use a force transducer, interfaced with an analog / digital computer program to accumulate and integrate the force / time data. 2) Firmly secure the hair in the transducer clamp, so that the hair will hang vertically. 3) When the measuring device is ready to run a test, start combing the hair in the tangled part, starting at the bottom of the hair. Be careful not to grab the hair with the other end because it could be recorded as
P1383 unwinding force blocking the registered force. Work with the comb gradually to the top of the hair as the knots are removed. 4) When the hair can be combed hair without getting stuck in any knot, make three more combing strokes and then stop combing. 5) Indicate to the software that the test was completed for each sample. 6) Remove the hair from the transducer clamp. 7) Carry out steps 1-6 (previous) for each change, conduct the hairstyle round-robin through the whole set of hair. 8) Calculate the average values and statistical differences using the Fisher's procedure
Least Significant Difference (LSD-Fisher's Minor Significant Difference), with a P value less than or equal to 1.0. The tested products must be significantly different at this point.
. Determination of the value of the index Compare the average combing force of each product examined against the average combing force of the control and calculate the proportion by dividing the combing force of the test product between the combing force
P1383 of the control. For example, if the test product receives a combing force of 1500 force / time units and the control receives a combing force of 1300 force / time units, then the value of the index of the test product is 1500/1300, which is equal to an index value of 1.15.
C. Method for evaluating the index of the second conditioning The index of the second conditioning is indicative of conditioning, as observed by the consumers of the composition of the shampoo. Generally, the value of the highest composition index, better is the conditioning, because the sensation of clean hair is increased. 1. Principle Product samples and control are applied to the horsetail of the hair using brushes. Trained sensory panelists will evaluate the "clean feeling" attribute of each change treated with product and each change treated with the control samples, using their thumb and index finger. The trained sensory panelists assign a numerical value from 0 to 10, with 10 being the highest amount of cleansing sensation. Within each test of
P1383 cleaning sensation, two test samples are evaluated against two anchors identified and a bandaged internal control. The index is calculated by comparing the value of the cleaning sensation attribute of the test product with respect to the value of the cleaning sensation attribute of the control. How well it qualified in the feeling of cleanliness is indicative of the conditioning function.
2. Equipment
Caucasian hair, horsetail, weight = 20 grams; length = 8 inches, commercially available at International Hair Importers and Products; 15 changes per product to test (6 for products, 9 for controls) Trained panelists 12 sensory panelists Conventional laboratory sink with a horizontal bar placed approximately 20 inches above it Water temperature = 100 ° F,
P1383 powered through a flexible hose Brushes 1 for tested hair; plastic brush commercially available in Goody Combs 1 for tested hair; barber plastic comb, approximately 9 teeth / inch Stopwatch Able to measure seconds Product 30cc of product per hair
3. Reagents
Raw Material Ancora Ancora Control High Internal Media Laureth-3 Sulfate 10.00 15.00 13.50 Ammonium Lauryl Sulfate 6.00 5.00 4.50 Ammonium Sarcosinate 1.50 1.50 Lauroyl Sodium MEA Cocamide 0.80
Pl383 Distearate of 1.50 1.50 1.50 ethylene glycol Dimethicone2 1.00 Dimethicone3 1.35 Polyquate 104 0.50 Polyquat 105 0.025 Guar gum 0.10 hydroxypropyltrimonium6 PEG 7M7 0.10 PEG 128 0.325 0.125 Phenidintiona zinc9 1.00 Homopolymer 1-decene 0.30 10
Capil Caprilato 0.10 trimethylpropane11 Cetyl alcohol 0.90 Sodium sulfate 0.875 0.875 DMDM Hydantoin 0.2475 0.2035 0.2035 Lauryl alcohol 0.15 0.15 Perfume 0.5 0.65 0.7 Water12 sufficient quantity-
1. Hamposyl L-30, as an active solution to 3 (
P1383 commercially available from Hampshire Chemical Company. 2. A mixture of dimethicone rubber SE-76 in proportion, based on weight, of 40 (gum) / 60 (fluid), commercially available in General Electric Silicones and a dimethicone fluid with a viscosity of 350 centistokes. 3. 300,000 centistokes silicone, commercially available in General Electric Silicones. 4. UCARE Polymer LR 400, commercially available in Amerchol. 5. UCARE Polymer JR 30M, commercially available in Amerchol. 6. Jaguar C 17, commercially available in Rhodia. 7. Poliox WSR N-750, commercially available from Union Carbide. 8. Carbowax 600, commercially available from Sentry Company. 9. ZPT with an average particle size of approximately 2.5 μm, commercially available from Arch / Olin. 10. Puresyn 6, commercially available in Mobil. 11. Mobil P43, commercially available in Mobil. 12. Adjust the pH of approximately pH 5 to
P1383 approximately pH 1, using the conventional pH modifiers.
4. Experimental procedure A. Preparation of false hair 1) All false hair must be cleaned and classified hierarchically before conducting each test to determine the index of the first conditioning in order to adjust the function of the uncontrollable variables between each untreated hair. of a given set. This classification procedure groups specific hair pieces into subsets or groups, so that the function of all the groups together is uniform. 2) Collect all the hair that will be used in the test. 3) Treat the hair in accordance with the protocol detailed in Part B below, using the initial composition of hair classification instead of the test products, however, still use the composition of the control where designated. 4) Two or three trained panelists should feel the hair and select a set of 3 false hair that feels similar. (A panelist is considered trained if the person is able to choose
P1383 the anchors high and low in a blind context as well as placing the internal control in the appropriate range. ) 5) These similar hair strands will be used to test 2 products and for internal control. The false hair for the high and low anchor are not classified.
B. Hairline Treatment 1) Hang a hair strand above the sink on a horizontal bar and wet it completely using water at 100 ° F and at a flow rate of 1.5 gallons / minute. 2) Squeeze the excess water. 3) Apply 0.4 cc of a test sample or control uniformly down of the hair, using at least 8 false hair per product examined. Apply the samples to the hair in a round-robin fashion, for example hair # 1 of each set-sample # 1, then hair # 1 of each set, sample # 2, etc. An example is to apply in the following order: LA, IB, 1C, 2A, 2B, 2C, 3A, 3B, 3C, etc., where the letters refer to a product to be tested and the numbers refer to a replicative number. 4) Brush the hair for 30 seconds at a speed of one brushed per second.
P1383 5) Rinse hair with water at 100 ° F for 30 seconds. Support the back of the hair, while waiting for the water to wet the hair completely. 6) Flip the hair and apply 5cc of the same sample to the other side of the hair and work the product inside. 7) Brush the product through the artificial hair for 30 seconds at a speed of one brushed / second. 8) Rinse the hair for 30 seconds at a rate of approximately one brush / second. Support the back of the hair, while allowing water to pass down the entire hair. 9) Perform steps 1-8 a second time. 10) Perform steps 1-8 a third time.
C. Hairline evaluation 1) After completing steps 1 to 10
(formerly in Part B) trained panelists will evaluate false hair. 2) Hang five changes in the sink, identifying each change treated with the major looper and a change treated with the lower looper. Identify the hair
P1383 postizo that was treated with the internal control and the hair hair treated with the two different test products, simply as "A," "B," and "C." The internal control label must vary between test and test to prevent bias. 3) Trained panelists should evaluate the hair using the following protocol: 4) Trained panelists should not soak their hair, but can comb it (using a different comb on each change) to realign the hair. 5) With one hand, the trained panelists' thumb is placed in front of the hair while the index and middle fingers are on the back of hair. Using moderate pressure, the hair is pushed with the thumb. This movement continues downward along the hairline. It is important to make an up and down movement, as opposed to side to side, as the sensations are different. 6) Using the high and low anchors as guides, the trained panelists should assign a numerical value to each hairline marked A, B, and C evaluating the cleanliness, the hair feeling of each one. The low looper must be assigned a value of 0 and the high locus of 10.
(While for panelists it is unknown, the value of the internal control is typically about 2.5 to
P1383 approximately 4.0.) 7) Each set of treated hair is evaluated by four panelists and then removed. 8) Record all values assigned to all false hair by all trained panelists. 9) Calculate the average values and the statistical difference using Fisher's Minor Significant Difference (LSD) procedure, with a P value less than or equal to 1.0. The tested products must be significantly different at this level.
. Determination of the value of the index Compare the average value of the cleanliness attribute of the test product against the average value of the cleanliness attribute of the internal control and calculate a proportion by dividing the value of the cleanliness attribute of the test product between the value of the cleaning sensation attribute of the internal control. For example, if the test product receives a value of the cleanliness attribute of 2.0 and the internal control receives a value of the clean feeling attribute of 3.5, then the index of the test product is 2.0 / 3.5, which is the same to an index value of 0.57.
P1383 D. Minimum inhibitory concentration The minimum inhibitory concentration index is indicative of anti-dandruff efficacy. Generally, the higher the value of the composition index, the better the anti-dandruff efficacy, due to an increased inherent ability of the antidandruff agent to inhibit the growth of microorganisms.
1. Principle Malassezia fúrfur is incubated in a flask containing the mDixon medium (see E. Gueho, et al., Antoinie Leeuwenhoek (1996), No. 69, 337-55, the description of which is incorporated in this invention). Dilutions of the solubilized antimicrobial active are added to the test tubes containing the melted agar of mDixon. The inoculum of M. fúrfur is added to each tube of molten agar, the tube with vortex, and the contents are poured into sterile Petri dishes separately. After the boxes are incubated, the visible growth of M. fúrfur is observed. The lowest antimicrobial active test dilution that does not produce growth is defined as the minimum inhibitory concentration (MIC). A value of the MIC index is calculated by comparing the MIC value for the antimicrobial active with the MIC value for ZPT. The MIC index value is indicative of the power of an asset
Pl383 antimicrobial.
2. Equipment / Reagents
Microorganism Malassezia fúrfur (ATCC 14521) Erlenmeyer flask 250 ml Agar medium 9.5 ml mDixon agar by concentration per active to be tested Solvent water, dimethyl sulfonyl oxide ("DMSO"), others suitable for active ingredients to be examined Pyridinthione zinc ZPT with a particle size of approximately 2.5 μm, preserved in Darvan, commercially available from Arch / Olin Test tubes 2 tubes per active antimicrobial by concentration per active to be examined, sterilized, size = 18 mm x 150 mm Petri dishes 2 boxes per asset
Pl383 antimicrobial by concentration to be tested, sterilized, size = 15 mm x 100 mm
3. Experimental procedure 1) Cultivate Malassezia fürfur in a 250 ml Erlenmeyer flask containing 100 ml of mDixon medium at 320 rpm and 30 ° C until cloudy. 2) Prepare the selected dilutions, using a series of dilutions in half, of the antimicrobial active in solvent, which allows the sample asset to be solubilized before adding it to the final test. For each concentration of ZPT samples, the solvent can be DMSO; For other samples, the solvent must be water or DMSO or other suitable solvents. 3) Add dilutions of 0.25 ml of the antimicrobial active to the test tubes containing 9.5 ml of molten mDixon agar (at 45 ° C in a water bath). 4) Add 0.25 inoculum of M. fúrfur (adjusted to 5 x 105 cfu / ml per direct count) to each test tube of molten agar. 5) Vortex each tube and pour the contents into Petri dishes separately. 6) After the agar has solidified,
Pl383 invert the boxes and incubate them at 30 ° for 5 days. 7) Observe in the boxes a visible growth of M. fúrfur.
4. Determination of the value of the index Determine the value of the MIC index by comparing the MIC for each antimicrobial active in relation to that of ZPT, dividing the MIC value by ZPT between the MIC value for the tested antimicrobial active. For example, if the MICZPT value is 1.0 μg / g and the MlCtest value is 4.0 μg / g, then the index for the test asset is 1.0 μg / g / 4.0 μg / g, which is equal to the value of the 0.25 index. .
EXAMPLES The following are non-limiting examples of compositions of the antidandruff conditioning shampoo of the present invention. The examples are given for illustrative purposes only and should not be translated as limitations of the present invention, since any of their variations are possible without departing from the spirit and scope of the invention, which will be recognized by those who dominate the technical field. In the examples, all concentrations are listed as percentages by weight, unless otherwise specified. As used in this
Pl383 invention, "minor" refers to optional components such as preservatives, viscosity modifiers, pH modifiers, fragrances, foam propellants and the like. As is evident to those who dominate the technical field, the selection of those minors will vary depending on the physical and chemical characteristics of the ingredients particularly selected to elaborate the present invention, as described in this invention. A suitable method for the preparation of antidandruff shampoo compositions described in Examples I-IX (below) reads: Approximately one third of all ammonium laureth sulfate
(added as 25% by weight of the solution) is added to a jacketed tank and heated from about 60 ° C to about 80 ° C with slow stirring to form a solution of the surfactant. Cocamide MEA and fatty alcohols, (where applicable), are added to the tank and allowed to disperse. The salts (for example sodium chloride) and the pH modifiers (for example citric acid, sodium citrate) are added to the tank and allowed to disperse. The ethylene glycol distearate ("EGDS") is added to the mixing vesicle and is to be infused. After the EGDS is melted and dispersed, a preservative is added to the solution of the
P1383 surfactant. The resulting mixture is cooled from about 25 ° C to about 40 ° C and collected in a finishing tank. As a result of this cooling step, the EGDS crystallizes to form a crystalline lattice in the product. The remaining ammonium laureth sulfate and other components, including the silicone and the antidandruff agent, are added to the finishing tank with agitation to ensure a homogeneous mixture. The cationic polymer is dispersed in the water as an aqueous solution of about 0.1% to about 10% and added to the final mixture. Once all the components have been added, additional viscosity and pH modifiers can be added, as needed, to the mixture to adjust the viscosity and pH of the product as desired.
Sample number I II III IV V
Laureth Ammonium Sulfate 1 111 9 10 10 11.5
Lauryl ammonium sulfate 6 7 6 7 6.5
Polyquaternium-1O1 0.35 0.35 0.5 0.1 0.45
Chloride Guar 0.25 0.25 0.4 Hydroxypropyltrimonium2 PEG7M3 0.1 0.05 0.1 0.05 0.15
Zinc pyrithione4 1 1 1 1 1
Homopolymer of 1-decene5 0.25 0.4 0.3 0.25 0.3 Capil Caprilato of 0.1 0.2 0.1 0.1 0.15 trimethylpropane6 Dimethicone7 2.55 3.25 1.35 3.25 2.55
Ethylene glycol distearate 1.25 1.0 1.5 1.0 1.5
Cocamida MEA 1.0 0.6 0.8 0.6 0.8
Cetyl alcohol 0.6 0.6 0.9 0.9 1.0
Water and less enough
Sample number vi VII VIII IX
Laureth Ammonium Sulfate 10 10 11 10
Lauryl ammonium sulfate 6 6 6 7
Polyquaternium-101 0.5 0.6 0.35
Chloride Guar 0.5:: 0.15
Hydroxypropyltrimonium2 PEG7M3 0.1 0.1
Zinc pyrithione4 1 1 1 1
Homopolymer of 1-decene5 0.4 0.4 0.3 0.4
Capil Caprilato 0.1 0.1 0.1 0.1 trimethylpropane6 Dimethicone7 2.5 2.25 1.5 1.5
Ethylene glycol distearate 1.5 1.5 1.0 1.25
Cocamida MEA 0.8 1.0 0.9 0.6
Cetyl alcohol 0.9 0.9 1-1 1.0
Water and minors
P1383 1. UCARE Polymer LR400, available from Amerchol. 2. Guar with a molecular weight of approximately 200,000, and with a charge density of approximately 0.71 meq / g, available from Aqualon. 3. Poliox WSR N-750, available from Union Carbide. 4. ZPT with a particular average size of approximately 2.5μm, available in Arch / Olin. 5. Puresyn 6, available on Mobil. 6. Mobil P43, available in Mobil. 7. Visasil 330,000 centistokes, available in General Electric Silicones.
Next, the four values of the indexes of examples III, VI, and VII are tabulated.
Example Number III VI VII Index value of 2.48 2.02 3.25 coverage / bioavailability Index value of the first 0.92 0.91 0.92 conditioning Index value of 2.62 1.74 2.30 second conditioning Index value of 1.0 1.0 1.0
P1383 minimum inhibitory concentration P138
Claims (14)
1. A shampoo composition with the feature that it comprises: a) from 5% to 50% by weight, of an anionic surfactant; b) from 0.01% to 10% by weight, of a non-volatile conditioning agent; c) from 0.1% to 4% by weight, of an antidandruff agent; d) from 0.02% to 5% by weight, of a cationic polymer; e) water; where this composition: i) has a bioavailability / coverage index value of at least 1.25; ii) has a first value of the conditioning index, less than or equal to 1.0; iii) has a second value of the conditioning index, of at least 1.5; and iv) it has a value of the minimum inhibitory concentration index of at least 0.125.
2. A shampoo composition according to claim 1, wherein the composition has a value Pl383 of the coverage / bioavailability index of at least 1.5, preferably at least 2.0, and a minimum inhibitory concentration index value of at least 0.25, preferably at least 0.50.
3. A shampoo composition according to any preceding claim, wherein the composition has a first conditioning index value less than or equal to 0.96, preferably less than or equal to 0.91, and a second conditioning index value of at least 1.75. , preferably of at least 2.50.
4. A shampoo composition according to any preceding claim, wherein the composition further comprises from 0.1% to 10%, by weight of the composition, of a suspending agent, preferably wherein the suspending agent is ethylene glycol distearate.
5. A shampoo composition according to any preceding claim, wherein the non-volatile conditioning agent is a dispersed silicone.
6. A shampoo composition according to any preceding claim, wherein the anti-dandruff agent is selected from a group consisting of: ketoconazole and a zinc salt of l-hydroxy-2-pyridinothione, preferably wherein the zinc salt of the -hydroxy-2-pyridinothione are platelet-shaped particles.
7. A shampoo composition according to any P1383 preceding claim, wherein the composition is characterized in that it comprises from 0.1% to 1% of the cationic polymer.
8. A shampoo composition according to any preceding claim, wherein the cationic polymer is selected from the group consisting of: guar derivatives, preferably guar hydroxypropyltrimonium chloride; cellulose derivatives, preferably Polyquaternium-10; and its combinations.
9. A shampoo composition according to any preceding claim, wherein the guar derivatives have a molecular weight of 50,000 to 2,500,000, preferably from 50,000 to 700,000, and a charge density of 0.1 meq / g to 0.9 meq / g, and in wherein the cellulose derivatives have a charge density of 0.1 meq / g to 1.0 meq / g, preferably 0.2 meq / g to 0.6 meq / g and a molecular weight of 250,000 to 850,000, preferably 350,000 to 500,000. A shampoo composition according to any preceding claim, wherein the composition further comprises from 0.005% to 1.5% by weight of the composition, preferably from 0.5% to 1.0% of a polyalkylene glycol corresponding to the formula: P1383 a) wherein R is selected from the group consisting of hydrogen, methyl and combinations thereof, and b) wherein n is an integer having an average value of from 1,500 to 120,000, preferably from 3,500 to 15,000. 11. A shampoo composition characterized in that it comprises: a) from 10% to 25% by weight, of an ammonium surfactant; b) from 0.01% to 5%, by weight of the composition, of an insoluble and non-volatile silicone conditioning agent; c) from 0.3% to 2%, by weight of the composition, of a zinc salt of l-hydroxy-2-pyridinothione; d) from 0.1% to 1.0%, by weight of the composition, of a cationic polymer; e) water; wherein the composition: i.) has a value of the coverage / bioavailability index, as defined in this P1383 invention, of at least 1.5; ii) has a first value of the conditioning index, as defined in this invention, less than or equal to 0.96; üi) has a second value of the conditioning index, as defined in this invention, of at least 1.5; and iv) has a value of the minimum inhibitory concentration index, as defined in this invention, of at least 0.25. 12. A method for providing anti-dandruff efficacy and for conditioning hair characterized in that it comprises: a) wetting the hair with water; b) application to the hair of an effective amount of a shampoo composition according to any preceding claim; and c) rinsing the hair shampoo composition using water. A shampoo composition according to any preceding claim, wherein the composition is further characterized in that it comprises from 0.001% to 15% of a hair growth regulating agent selected from the group consisting of zinc salts of carboxylic acids, saponins, triterpenes, oleanolic acid,P1383 ursolic acid, betulinic acid, betulonic acid, crataegolic acid, celastrol, Asian acid, inhibitors of 5-a-reductase, progesterone, 1,4-methyl-4-azesteroids, 17-ß-N, N-diethylcarbamyl-4- methyl-4-aza-5-a-hydrostan-3-one, hydrogen receptor antagonists, cyproterone acetate, minoxidil, azelaic acid and its derivatives, cyclosporin, triiodothyronine, diazoxide, potassium channel openers, cromakaline, phenytoin, ketoconazole, finasteride, dutasteride, coal tar, zinc gluconate, glucocortisoids, macrolides, aminaxyl, and combinations thereof. 14. A method for regulating hair growth characterized in that it comprises: a) wetting the hair with water; b) application to the hair of an effective amount, of a shampoo composition according to any preceding claim; c) rinsing the hair shampoo composition using water. Pl383
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/132,867 | 1999-05-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01011220A true MXPA01011220A (en) | 2002-06-05 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6974569B2 (en) | Shampoos providing a superior combination anti-dandruff efficacy and condition | |
US6649155B1 (en) | Anti-dandruff and conditioning shampoos containing certain cationic polymers | |
US6451300B1 (en) | Anti-dandruff and conditioning shampoos containing polyalkylene glycols and cationic polymers | |
EP0889715B1 (en) | Conditioning shampoo compositions containing select hair conditioning esters | |
US6221817B1 (en) | Conditioning shampoo composition | |
EP0907346B1 (en) | Conditioning shampoo compositions containing select hair conditioning agents | |
EP0889716B1 (en) | Conditioning shampoo composition | |
EP0889713B1 (en) | Conditioning shampoo compositions containing polyalphaolefin conditioner | |
MXPA04011712A (en) | Conditioning shampoo containing aminosilicone. | |
MXPA04011711A (en) | Shampoo containing a gel network. | |
US6007802A (en) | Conditioning shampoo composition | |
MXPA01011220A (en) | Shampoos providing a superior combination of anti-dandruff efficacy and conditioning | |
MXPA01011221A (en) | Anti-dandruff and conditioning shampoos containing polyalkylene glycols and cationic polymers | |
MXPA01011219A (en) | Anti-dandruff and conditioning shampoos containing certain cationic polymers | |
MXPA98007940A (en) | Composition of champu acondiciona |